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T h e D u a l Role of O C A - B in B Cell D e v e l o p m e n t a n d Signaling 
Rachael Siegel, Ph.D. 
T h e Rockefeller University 2 0 0 6 
OCA-B (Oct coactivator from B cells) is a B-cell specific coactivator of 
transcription that acts in conjunction with the ubiquitously expressed 
activator, OCT-1 or the B cell-restricted OCT-2. OCT-1 or OCT-2 can 
bind an upstream octamer element with the consensus sequence 5'-
ATGCAAAT-3' in target gene promoters and enhancers. At the octamer 
element, the OCT-1/2-OCA-B complex is able to regulate gene expression 
via interaction with the basal transcription machinery. OCA-B was 
originally identified as a nuclear transcriptional coactivator and then 
shown to be essential for antigen-driven immune responses, including 
secondary isotype expression, germinal center formation and BCR-
dependent proliferation. These defects contribute to the severely 
impaired antigen-dependent immune responses of Oca-b^- mice. The 
later identification of a membrane-bound, myristoylated form of OCA-B 
suggested additional, potentially unique functions in B cell signaling 
pathways and that OCA-B might function through both transcriptional 
and non-transcriptional mechanisms within the cell. Therefore, a strong 
focus was placed on identifying additional OCA-B target genes that could 
explain its role in the antigen-dependent immune response. 
Importantly, this study has identified, by c D N A microarray, several genes 
that fail to be up regulated in the Oca-b^- activated B cells. OCA-B 
deficient cells have a compromised response to BCR signaling and many 
of the identified OCA-B target genes (e.g. Kcnn4, Lck, CyclinD3, and 
Cdc37) play important roles in cell signaling; however, their specific 
functions in B cell development and activation are largely unknown. 
From multiple primary B cell stages, we have found that key OCA-B 
target genes are expressed and regulated throughout B cell development. 
This study has identified a novel developmental block in Oca-b^- mice, 
which indicates that OCA-B also functions in the pre-Bl to pre-B2 cell 
transition by mediating pre-BCR signaling. Most surprisingly, OCA-B 
directly interacts with SYK, a tyrosine kinase critical for pre-BCR and 
BCR signaling. This unprecedented type of interaction — of a 
transcriptional coactivator with a signaling kinase — takes place in the 
cytoplasm and directly regulates SYK stability. Combined with the 
deregulation of OCA-B target genes, this may help explain both 
previously observed defects in the antigen-dependent immune response 
of Oca-fr/- mice and newly identified defects in early B cell development. 
This study indicates that OCA-B is required for a complete response to 
pre-BCR and BCR signaling at multiple stages of B cell development, 
through its non-transcriptional regulation of SYK. 
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C H A P T E R 1 
I N T R O D U C T I O N 
B lymphocyte development is a complex process marked by 
characteristic changes in gene expression and cellular phenotype. The 
generation of mature/antigen-responsive B cells from undifferentiated 
bone marrow precursors is dependent on the transmission of signals 
from both the extracellular and intracellular environments. One of the 
major mechanisms that enables this process to occur is transcriptional 
regulation. The alteration of gene expression resulting from cell signaling 
is critical for the development and function of B cells by driving changes 
in cellular function. Furthermore, antigen-dependent B cell 
differentiation is a useful model to study the mechanisms by which cells 
mediate alterations in gene expression in response to extracellular 
signals. Related, transcription of immunoglobulin genes has served as a 
model for understanding complex gene regulation because 
immunoglobulin expression is highly controlled throughout B cell 
development. This control is two-fold, involving gene alterations (V(D)J 
recombination, somatic hypermutation, and isotype switching) and 
events at DNA regulatory regions (enhancers and promoters). 
Immunoglobulin transcriptional regulation is mediated by transcriptional 
activators acting in conjunction with components of the basal 
transcriptional machinery upon binding of proximal/ promoter or 
distal/enhancer regulatory elements. Full activity of immunoglobulin 
promoters and enhancers require the function of multiple transcription 
factors, including OCT-1/2, PAX-5, PU.l, and NFk-B. The nature of the 
regulation of immunoglobulin and other immunologically relevant target 
genes by OCT transcription factors and the coactivator OCA-B in 
response to B cell signaling is the subject of this study. 
Octamer-dependent Regulation of immunoglobulin Gene Expression 
The promoters of immunoglobulin genes contain a TATA box at which the 
basal transcription machinery (RNA Polymerase II and general 
transcription factors) acts. In addition to the core promoter, the primary 
cis element that confers cell-type specificity of immunoglobulin gene 
expression is an essential upstream octamer motif with the consensus 
sequence, 5'-ATGCAAAT-3', or the reverse, 5'-ATTTGCAT-3' (Falkner and 
Zachau, 1984; Parslow et al., 1984, reviewed in Staudt and Lenardo, 
1991). Subsequent studies have shown that there is an octamer 
element in all immunoglobulin promoters and enhancers that is typically 
90-100bp upstream of the core promoter (reviewed in Staudt and 
Lenardo, 1991, Falkner and Zachau, 1984). The octamer element of 
immunoglobulin promoters has been extensively dissected by several 
mutagenesis studies to show that while some deviation can be tolerated, 
residues 4-6 are most critical for function in the context of 
immunoglobulin promoters (Cepek et al., 1996; Gstaiger et al., 1996). 
However, a consensus octamer element alone can not confer specificity of 
immunoglobulin expression because it is found in a diverse array of gene 
promoters such as the histone 2B (H2B), HSV immediate early, and 
s n R N A promoters (Sive et al., 1986; apRhys et al., 1989). B cell 
specificity could be mediated, in part, by regulation at additional 
functional elements (reviewed in Calame and Sen, 2004). For example, 
DICE, an IgH promoter element, was recently shown to be required for 
optimal Vh promoter activity (Tantin et al., 2004). Another recent study 
indicates that an 18bp element downstream of the IgK transcription start 
site also effects octamer dependence (Casellas et al., 2002). However, the 
factors that bind to this site have yet to be identified. 
Members of the POU (Pit, Oct, Unc) family of transcriptional activators 
are characterized by their ability to bind octamer elements via their POU 
domains. The family members, PIT-1, OCT-l/OCT-2, and UNC86 bind 
octamer elements in growth hormone and prolactin promoters, 
immunoglobulin promoters, and various Caenorhabditis elegans gene 
promoters, respectively (reviewed in Phillips and Luisi, 2000). Structural 
and biochemical studies indicate that these regulators are comprised of 
only two conserved domains, the POU specific and the POU 
homeodomains, which are joined by a flexible linker. The POU specific 
domain interacts with the ATGC octamer half site while the 
homeodomain interacts with other. 
Of the POU proteins that activate immunoglobulin transcription, OCT-1 
is ubiquitous, whereas OCT-2 is mainly lymphocyte specific (Landolfini et 
al., 1986; Staudt et al., 1986; Scheidereit et al., 1987). Historically, 
OCT-2 was originally thought to be responsible for mediating B cell 
specificity of immunoglobulin expression; however, it was later shown to 
be dispensable for immunoglobulin transcription in vitro /Pierani et al., 
1990; Luo et al., 1992). Subsequent analysis of Oct-2-/- mice confirmed 
that OCT-2 is not strictly required for immunoglobulin expression in vivo 
(Corcoran et al., 1993; Feldhaus et al., 1993). The first evidence for an 
additional factor being involved in immunoglobulin transcription came 
from the demonstration by Pierani et al. that addition of recombinant 
OCT-1 and/or OCT-2 was not sufficient to achieve high levels of IgH 
transcription in OCT depleted nuclear extracts. Furthermore, efficient 
IgH transcription was only produced in Hela cell nuclear extracts if 
purified OCT factors from B cells were added as opposed to recombinant 
OCT proteins. Thus, indicating that there was a unique factor present in 
purified OCT fractions from B cell nuclear extracts that could allow for 
high immunoglobulin transcription. This activity, which proved to be 
OCT-1-associated was purified and shown to function in conjunction 
with OCT-1 or OCT-2 to activate IgH transcription in vitro (Luo et al., 
1992). This factor was designated OCA-B, for Oct coactivator from B cells 
(Luo et al., 1992). In the presence of OCT-1, addition of OCA-B to a non-
B cell nuclear extract allowed for recapitulation of IgH expression, similar 
to that of a B cell extract. Importantly, OCA-B was found to have no 
effect on the octamer-containing H2B promoter (Luo et al., 1992). 
OCA-B:OCT:DNA Ternary Complex Formation and Transcriptional 
Activation (Figure 1.1) 
Cloning and further analysis revealed that OCA-B is proline-rich, 256 
amino acid protein with B cell-restricted expression (Luo and Roeder, 
1995). Detailed biochemical analysis revealed that OCA-B functions 
efficiently with both OCT-1 and OCT-2 in vitro (Luo and Roeder, 1995; 
Luo et al., 1998). OCA-B was also cloned by yeast one-hybrid screens 
using OCT-1 as bait, and is also referred to as OBF-1 or BOB1 (Gstaiger 
et al., 1995; Strubin et al., 1995). While OCA-B interacts with both the 
POU-specific and POU-homeodomains of OCT-1/2, it does not interact 
with other members of the family (Luo and Roeder 1995; Gstaiger et al., 
1996; Babb et al., 1997). The POU domains alone of OCT transcription 
factors are sufficient for recruitment and interaction with OCA-B but not 
for transactivation of IgH promoters, which indicated that OCA-B can not 
activate transcription alone (Luo and Roeder, 1995; Luo et al., 1998). 
However, provided that there is an A at position 5, OCA-B alone has a 
slight affinity for the octamer but is remains unable to activate 
transcription without OCT-1/2 (Luo and Roeder, 1995; Cepek et al., 
1996; Chasman et al., 1999). Mutagenesis studies have identified the 
N-terminal 65 residues of OCA-B to be required for interaction with POU 
transcription factors (reviewed in Luo and Roeder, 1999). Conversely, 
the transactivation domain of O C A - B is located within an acidic region of 
the carboxy terminus surrounding position 240 (Luo et al., 1998). 
While the mechanism of OCA-B-mediated transcriptional activation has 
not yet been completely determined, full activation of IgH transcription in 
a reconstituted system requires both OCA-B and components of the 
general cofactor USA fraction (Meisterernst et al., 1991; Luo and Roeder, 
1995). These studies were extended to show that PC4 depleted USA 
fractions could not support OCA-B function in a reconstituted system 
(Luo et al., 1998). However, PC4 depleted Hela cell nuclear extract could 
still support activated IgH transcription, which suggests that the extract 
has a redundant activity for PC4 that was not present in that USA 
fraction. The OCA-B/PC4 interaction was further demonstrated by GST-
pulldown and localized to the activation domain of OCA-B, which is 
consistent with PC4 playing a role in OCA-B-mediated gene activation 
(Luo et al., 1998). GST-OCA-B pulldown has also revealed an 
interaction with TBP and TFIIB (Schubart et al., 1996a) but this finding 
has yet to be investigated further. Additionally, OCA-B-dependent 
activation was also shown to require PC2/Mediator (Luo et al., 1998). 
The mediator is a large multi-subunit complex that is the main link of 
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transcriptional regulatory factors and cofactors to the general 
transcriptional machinery (reviewed in Malik and Roeder, 2000). 
What still remains unclear, in part, is why OCA-B only functions from 
some consensus octamer-containing promoters. There are multiple 
mechanisms that are likely to contribute to OCA-B function on a subset 
of octamer-containing promoters. First, OCA-B function could be 
dependent on which factors are present at the core promoter and/or the 
sequence surrounding the octamer element could affect assembly of the 
OCA-B/OCT/DNA complex. TATA box swapping experiments between 
the H2B and IgH promoters indicate that an IgH promoter with an H2B 
TATA box becomes less responsive to OCA-B (Kim et al., unpublished; 
reviewed in Luo and Roeder, 1999), suggesting that elements at the core 
promoter play a role in the ability of OCA-B to function from an octamer 
element. Alternatively, it is possible that additional OCT coactivators 
exist in different cell types. Indeed, an activity, distinct from OCA-B has 
been identified that can stimulate IgH transcription in vitro (Fujii et al., 
unpublished data). Furthermore, OCA-S, an OCT coactivator that is 
necessary for H2B gene expression has recently been identified (Zheng et 
al., 2004). 
It is possible that OCA-B can impart selectivity by not only facilitating 
interaction with the basic transcription machinery via transactivation, 
but also by targeting specific octamer sequences. Mutagenesis and 
crystallization studies indicate that an A residue at the fifth position of 
the octamer element is critical for recognition by OCA-B. The crystal 
structure of the POU/OCA-B/DNA complex indicates that OCA-B makes 
contact with this residue (Cepek et al., 1996). Another, related 
mechanism that has been suggested to effect specificity is that OCA-B 
binding to promoter-bound OCT-1/2 could potentially be decided by the 
sequence immediately upstream of the octamer element (Tomilin et al., 
2000; Remenyi et al., 2001). In this model, OCT proteins homo- or 
hetero-dimerize on the IgH promoter dependent on a heptamer and an 
octamer element separated by a few bases (Kemler et al., 1989; LeBowitz 
et al., 1989; Polleinger et al., 1989). According to this model, 
heptamer/octamer-containing promoters would not be activated by OCA-
B. However, a heptamer/octamer-containing promoter is OCA-B-
dependent as judged by in vitro transcription assays (Luo et al., 1992), 
indicating that this model may have limitations. 
Yet another mechanism by which OCA-B promoter specificity can be 
obtained is indicated by the study of Casellas et al. which found that 
only some Vk gene promoters require OCA-B for expression regardless of 
the type of octamer sequence they contain (Casellas et al., 2002). This 
study reopened investigation in to an 18bp element that lies downstream 
of the transcriptional start site because it is absent in the OCA-B 
10 
dependent Vk promoter subset. It is speculated that this element, w h e n 
present, could have a strong enough effect to make OCA-B dispensable 
for some Vk promoters. In conclusion, it seems that OCA-B function at 
octamer-containing promoters is dictated by a combination of 
mechanisms and that this may be an important method by which the cell 
is able to tightly regulate immunoglobulin expression. 
The Role of OCA-B in IgH Enhancer Function (Figure 1.2) 
The IgH locus has two well-documented enhancers that, collectively, 
contain binding sites for NFk-B, E2A, PAX-5, ETS proteins, and OCA-
B/OCTs. The first enhancer (E^,) is intronic and lies between the 3'-
most V(D)J segment and the C\i region. The contribution of this 
enhancer to immunoglobulin expression has been well characterized and 
it contains several consensus octamer elements (Neuberger, 1983; Tsao 
et al., 1988; Jenuwein and Grosschedl, 1991). The second IgH enhancer 
that lies 15kb downstream of the Ca region spans 40kb and is comprised 
of multiple hypersensitive sites (four in mice, three in humans) (reviewed 
in Khamlichi et al, 2000). In mice the 3' enhancer elements are HS3a, 
HS1,2, HS3b, and HS4; which all contain consensus octamer elements 
(Matthias and Baltimore, 1993, Pettersson et al., 1990; Lieberson et al., 
1991; Madisen and Groudine, 1994; reviewed in Khamlichi et al, 2000). 
Originally, the HS elements of the 3' enhancer were thought to function 
separately; however, their synergism is required to achieve strong 
11 
promoter activation (Ong et al, 1998). Although synergism between E\x 
and the 3' enhancer has been demonstrated in vitro, the two enhancers 
are distinctly developmentally regulated in vivo (Ong et al., 1998; 
reviewed in Arulampalan et al., 1997). E^i shows a constant level of 
activity throughout B cell development and is required for Vh gene 
arrangement and expression. Conversely, the activity of the 3' enhancer 
increases with B cell maturity and is required for the germline 
transcription that proceeds isotype switching (Stevens et al., 2000, 
reviewed in Arulampalam et al., 1997). Furthermore the 3' enhancer is 
also required for the expression of switched isotypes. For example, 
secondary isotype expression (IgA) is severely reduced in a plasma cell 
line that has lost the 3' enhancer (reviewed in Cogne et al., 2003). 
Studies on the individual contribution of the 3' enhancer elements show 
that HS3 and HS1,2 are more active in mature cells, whereas HS4 is 
active throughout B cell development. However, all of the elements 
contribute synergistically to the collective activity of the 3' enhancer 
(Michaelson et al., 1991; Chauveau et al., 1998; Chauveau et al., 1999; 
Anderson et al., 1999; Ong et al., 1998; Stevens et al., 1999). 
OCA-B is likely to play a critical role in secondary isotype expression by 
functioning at immunoglobulin enhancers. While E\x activity is less 
dependent on OCA-B, the 3' enhancer requires OCA-B for full activity, 
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which is increased with O C A - B inducing signals such as C D 4 0 and IL-4 
(Stevens et al., 2000). Similar findings were reported in a study using an 
HSl,2-containing reporter transgene in an Oca-b/- background 
(Anderson et al., 2000). More recently, both the murine and human 
HS4 were shown to require synergistic binding of NFk-B and OCT-1/2 for 
full activity (Sepulveda et al., 2004). Importantly, HS4 is affected by the 
expression level of OCA-B such that HS4 activity is high in a Burkitt's 
lymphoma cell line, which has high OCA-B/OCT-2 expression. 
Conversely, 3' enhancer activity is reduced in plasma cell lines that have 
limited expression of OCA-B or OCT-2 (Sepulveda et al., 2004). The 
important role of HS4 in expression of switched isotypes is evidenced by 
targeted deletion of HS3a or HS1,2 having no effect on class switch 
recombination or secondary isotype expression (Manis et al., 1998). 
Thus, it is likely that OCA-B mediates IgH expression via HS4 or the 3' 
enhancer. 
Genetic Analysis of OCA-B Function 
To analyze OCA-B function in a more physiological setting, knockout 
mice were generated using targeted gene deletion (Kim et al., 1996; 
Nielsen et al., 1996; Schubart et al., 1996b). The phenotype of Oca-b/-
mice is striking in that early B cell differentiation is largely normal, as is 
IgM expression, which at first seemed inconsistent with established OCA-
B function in vitro. However, normal IgM levels, is in accordance with 
14 
Oca-b/- mice having largely unaffected antigen-independent phases of B 
cell development. As mentioned previously, an additional OCA-B-like 
activity has been identified that may prove to be responsible for Vh 
promoter activation in early B cells (Fujii et al., unpublished data). The 
most notable features of Oca-b/- mice are the complete absence of 
germinal centers (reviewed in Maclennan, 1994, Ma and Staudt, 2001) 
and the severely reduced serum levels of secondary isotypes (IgA, IgGl, 
IgG2a, IgG2b, IgG3, and IgE), indicating that OCA-B is more important 
for later, antigen-dependent B cell development. Secondary isotype 
switching occurs normally in these mice but transcription of switched 
isotypes is impaired, which supports a role for OCA-B in heavy-chain 
transcription (Kim et al., 1996). As mentioned previously, the lack of 
switched isotypes in Oca-br/- mice could be linked to OCA-B function at 
HS4 of the IgH 3' enhancer (Sepulveda et al., 2005). Additionally, Oca-br 
/- B cells have reduced Calcium-flux and resulting proliferation in 
response to B cell receptor (BCR) cross-linking (Kim et al, 1996, 
Schubart et al., 1996; Nielsen et al., 1996; Kim et al., 2000). Consistent 
with Oca-br/- mice having normal T cell development and function, 
reconstitution experiments show that the defects of Oca-b/- mice are B 
cell autonomous (Qin et al., 1998). Recently, a slight defect in early B 
cell differentiation, a reduced number of cells in transition from the bone 
marrow to spleen (B220+IgMhi) resulting from increased apoptosis, has 
been reported in Oca-br/- mice (Hess et al., 2001). This defect may be 
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attributed in part to an impaired ability of Oca-b/- mice to activate a 
subset of Vk promoters (Vk4 and Vk3-833) (Casellas et al., 2002). 
Furthermore, there is also a reduction of transitional B cells in the 
spleen that may be linked to the skewed IgK repertoire and/or defective 
signaling in Oca-b/- mice (Jankovic et al., 2003). Additionally, Oca-b/-
mice have a pronounced reduction in recirculating B cells of the bone 
marrow (Schubart et al., 1996; Hess et al., 2001), which further suggests 
that these mice are defective in multiple signaling mechanisms. 
In addition to these studies using Oca-b/- mice, several double 
knockouts have been generated to better understand OCA-B function in 
B cell signaling pathways. These studies are of particular importance 
because full transcription of immunoglobulin genes requires the function 
of multiple transcription factors. However, Oct-2//Oca-b/- mice show 
defects similar to those seen in Oca-b/- mice (Schubart et al, 2001) 
suggesting that neither factor is absolutely necessary for heavy chain 
gene transcription. Btk and Oca-b double null mice display an 
enhancement of the Btk-/- phenotype, in that these mice completely lack 
peripheral B cells (Schubert et al., 2004), which suggests that the two 
proteins have overlapping functions and may both be involved in BCR 
signaling. Nfic-bl-/-/Oca-b/- mice maintain the Oca-br/- phenotype in 
addition to an interesting reduction in the B-la cell population and have 
further compromised conventional B-2 cell differentiation, which results 
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from a complete absence of T-independent and T-dependent i m m u n e 
responses (Kim et al, 2000). Additionally, these mice have reduced IgM 
and secondary isotype levels. This suggests that OCA-B and NFk-B have 
partially overlapping functions, playing cooperative roles in IgM 
production and Bl cell differentiation. As mentioned previously, a recent 
study has shown NFk-B and OCA-B cooperativity at HS4 of the 
immunoglobulin 3' enhancer (Sepulveda et al., 2004). 
Regulation of OCA-B Expression (Figure 1.3) 
Because most studies have focused on the function of OCA-B, the 
upstream signals mediating OCA-B expression are largely unknown 
despite that OCA-B expression is tightly controlled throughout B cell 
development and germinal center formation (Qin et al., 1998). 
Surprisingly, although OCA-B expression is normally restricted to B 
cells, its expression can be induced in T cells by stimulation with phorbol 
esters and ionomycin (Zwilling et al., 1997). However, due to the extreme 
method of stimulation used, the physiological relevance of OCA-B 
expression in T cells is unknown. However, these findings do suggest 
that OCA-B expression is differentially regulated by various signaling 
pathways such as those associated with BCR signaling and T cell help. 
Moreover, OCA-B can be induced in resting B cells by stimulation with 
LPS, anti-CD40 and IL-4 or BCR crosslinking (Qin et al., 1998). This 
finding was extended to show that in primary splenic B cells and 
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transformed B cell lines, O C A - B up-regulation by anti-CD40 and IL-4 is 
dependent on an intact CREB/ATF binding site (-64 to -57 BP) within its 
1.4KB promoter region (Stevens et al., 2000). Interestingly, CREB sites 
are often targets of BCR-derived cell signaling (Xie and Rothstein, 1995). 
Although induction of OCA-B is dependent on this site, the specific 
CD40-dependent pathway(s) mediating OCA-B induction is completely 
unresolved. This can be attributed to the magnitude and complexity of 
immune responses that are resultant of CD40-mediated signaling. The 
CD40-CD40L interaction on B cells results in the induction of many 
proteins other than OCA-B, such as those involved in the JNK/SAPK, 
NFk-B, p38 protein kinase, and ERK pathways (reviewed in Grammer 
and Lipsky, 2000). CD40- and CD40L-deficient mice present defects in 
multiple aspects of the immune response such as T cell priming, 
dendritic cell migration, germinal center formation and secondary isotype 
switching /Kawabe et al., 1994; Xu et al., 1994). Both CD40- and Oca-b-
deficient mice have a complete inability to form germinal centers and 
have severe defects in secondary isotype production. However, CD40-/- B 
cells do not undergo isotype switching, whereas Oca-br/- B cells fail to 
express switched isotypes. Because there is some overlap between the 
Oca-b/ and CD40-/- phenotypes, it would be useful to determine the 
extent that compromised OCA-B expression contributes to the 
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deficiencies of CD40-/- mice. This type of analysis could provide 
information on what CD40-mediated functions are downstream of OCA-B 
induction. 
Despite the interesting connection of OCA-B expression with CD40-
mediated signaling, more recent studies suggest that OCA-B is also 
heavily regulated at the protein level by ubiquitin-mediated degradation 
(Boehm et al., 2001; Tiedt et al., 2001). Degradation of OCA-B is 
mediated through its interaction with the RING-finger protein SIAH-1 
(Boehm et al., 2001; Tiedt et al., 2001). Therefore, it is likely that tight 
control of OCA-B expression is maintained through a combination of 
transcriptional and post-transcriptional regulatory mechanisms. 
Additional OCA-B Target Genes 
As mentioned previously, Oca-b/- mice lack germinal centers and have 
compromised responsiveness to B cell signaling, indicating that OCA-B is 
necessary for expression of genes critical for these processes. Octamer-
containing promoters in the Pu.l, Blr-1, B29/Igfi, and Bcl-2 genes have 
been reported to be activated by OCA-B; however, alterations in the 
expression of these genes have not been conclusively linked to the Oca-br 
/- phenotype. For example, changes in PU.l expression were not 
observed in Oca-br/ B cells (Chen et al., 1996; Wolf et al., 1998; Malone 
and Wall 2002; Iotsova et al, 1997; Kim et al., 2000). BLR-1 is a 
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chemokine receptor that is involved in B cell homing and Blr-1/- mice 
also lack germinal centers in some lymphoid organs (reviewed in Fu and 
Chaplin, 1999). However, the Oca-br/- and Blr-1/- phenotypes differ 
significantly in that Blr-1-/- mice can form germinal centers in the lymph 
node, have normal numbers of peripheral B cells, and have intact 
responsiveness to T-dependent antigens (Forster et al., 1996). Unlike 
Oca-b-/- mice, Blr-1-/- mice even develop ectopic germinal centers in the 
spleen upon immunization (Voigt et al., 2000). Therefore, reduction of 
BLR-1 expression does not fully account for the immune defects of Oca-h 
/- mice. Transient transfection assays indicate that IgP may also be an 
OCA-B target gene (Malone and Wall, 2002). Although it remains possible 
that reduced expression of Ig(3 contributes to the Oca-b/- phenotype, 
further investigation is needed to determine if it is a direct OCA-B target 
gene in vivo. Bcl-2 is an OCA-B target gene only in certain B cell subsets 
such as pre-B cells (Brunner et al., 2003). Furthermore, overexpression 
of BCL-2 in Oca-b/- mice restores the transitional B cell defect in bone 
marrow but does not alter the mature B cell phenotype (Brunner et al., 
2003). Similarly, removal of CD22, a negative regulator of BCR 
signaling, in Oca-br/- mice only rescues the transitional B cell defect 
(Samardzic et al., 2002). Also, CD22 surface expression is increased in 
Oca-b/- transitional B cells, which supports the view that OCA-B has an 
indirect role in CD22 expression. Thus, further study to identify 
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additional OCA-B target genes is necessary to understand O C A - B 
function in B cell differentiation and function. 
The Role of OCA-B in Signaling (Figure 1.4) 
Given that impairment of germinal center formation in OCA-B deficient 
mice is most likely attributed to a signaling defect one must consider new 
roles for this protein in vivo. Originally, OCA-B was purified as two 
isoforms, p35 and p34, thought to reflect protein modifications; however, 
further investigation revealed an additional isoform, p40, that is present 
at very low levels and unstable in B cells (Yu et al., 2001). Interestingly, 
p40 and p34 arise from different translational start sites on a common 
mRNA (Yu et al., 2001). After translation, p40 is rapidly processed into 
p35 and myristoylated at the N-terminus. Transfection assays with the 
two isoforms (p34 and p35) indicate that the two proteins have distinct 
subcellular localization patterns (Yu et al., 2001). P35 is more prominent 
in the membrane/cytoplasm, whereas p34 is more heavily localized 
within the nucleus. Moreover, the localization of p35 is dependent on 
myristoylation because mutation of the myristoylation site results in 
complete nuclear localization. Of note, some p35 is also found in the 
nucleus and, reciprocally a small amount of p34 is found in the 
cytoplasm; however, it is unknown if this is functionally significant (Yu et 
al., unpublished data). Possibly related, p34 and p35 can both act as 
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transcriptional coactivators by in vitro transcription assays (Luo et al., 
1992). 
The identification and characterization of distinct OCA-B isoforms 
suggests that p34 and p35 could have different functions in vivo and 
raises the interesting possibility that p35 could function more directly in 
B cell signaling through non-transcriptional mechanisms. This is an 
especially intriguing and valid possibility given that it is becoming 
increasingly obvious that OCA-B is broadly important for B cell 
development and function. One mechanism by which OCA-B could have 
a more widespread impact is by playing dual roles within the cell - by 
functioning directly in signaling pathways within the cytoplasm (p35) 
and by acting as a conventional transcriptional coactivator (p34) to 
regulate target gene expression. A direct role for OCA-B in BCR signaling 
is supported by the multitude of B cell subsets that are developmentally 
or functionally affected by Oca-b deficiency. Validation of this hypothesis 
would require a significant amount of investigation because not only 
would one need to demonstrate that OCA-B functions directly in 
signaling but additional (non-Ig) target genes would also need to be 
identified. 
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O C A - B Expression in B Cell L y m p h o m a s 
The possibility that OCA-B contributes to oncogenic transformation was 
first indicated by the finding that OCA-B expression could be controlled 
in a temperature sensitive Abelson virus-transformed pre-B cell line, 
such that expression of v-ABL causes an increase in OCA-B expression 
(Qin et al., 1998). Similarly, the OCA-B level is elevated in many 
transformed B cell lines, irrespective of developmental stage, whereas its 
expression is tightly controlled throughout normal B cell development. 
Pathological studies of human tumor samples and cell lines have shown 
that OCA-B expression is compromised in the classical form of Hodgkin's 
lymphoma (Stein et al., 2001; Theil et al., 2001; Hertel et al., 2002). 
Hodgkin's Reed Sternberg (HRS) cells (classical Hodgkin's tumor cells) 
are thought to be crippled GC B cells that, through a complex 
mechanism, are able to evade apoptosis despite the lack of a functional 
BCR (reviewed in Kuppers, 2002). Recent studies have demonstrated 
that HRS cells lack expression of important B cell markers such as Ig|3, 
TCL-1, IgH, IgL, OCA-B/OCTs due to epigenetic silencing (Ushmorov et 
al., 2004; Doerr et al., 2005). Importantly, ectopic expression of OCA-B 
and OCT-2 in HRS cell lines can partially restore immunoglobulin 
expression (Hertel et al., 2000), which not only indicates that OCA-B 
plays a role in regulating immunoglobulin gene expression, but also 
suggests that reduced OCA-B expression may be involved in the 
transformation of these cells. 
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Conversely, OCA-B expression is up-regulated in certain germinal center-
derived B cell lymphomas such as Burkitt's lymphoma, follicular 
lymphoma, and diffuse large B cell lymphoma (Greiner et al., 2000). 
However, in these studies there is no comparison of the protein levels 
seen in the lymphoma samples versus their non-malignant counterparts, 
making it difficult to determine if there is actually up-regulation of OCA-
B protein levels relative to normal germinal center B cells. 
The stage has been set to consider a possible role for OCA-B in 
oncogenesis; however, there is little published data that distinguishes 
whether OCA-B expression levels contribute either to the initial 
transforming events or to the maintenance of tumorigenicity or whether 
its alteration is merely a by-product of transformation. However, a very 
recent study demonstrates increased OCT-2 and OCA-B expression in 
follicular lymphomas bearing a translocation of the Bcl-2 gene to the 
immunoglobulin locus, t(14;18) (Heckman et al., 2005). Interestingly, 
siRNA of OCT-2 or OCA-B results in a significant reduction of BCL-2 
expression and increased apoptosis of the infected cells (Heckman et al., 
2005). This study indicates that OCA-B may be required for cell survival 
thus contributing directly to malignant transformation. 
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At the onset of this project, O C A - B appeared to be broadly important for 
B cell maturation and function through largely unknown mechanisms. 
The phenotype of Oca-br/- mice, although well characterized, is somewhat 
surprising because IgM transcription is largely intact. However, mature 
B cell differentiation is severely defective, which highlighted the need to 
identify additional (non-Ig) OCA-B target genes. Equally important, was 
the need to examine the role that OCA-B might play in B cell signaling, 
especially given that the myristoylated-p35 isoform had recently been 
identified. It was the hope that information obtained from both of these 
approaches could be combined to explain the mechanism by which OCA-
B functions in B cells. 
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C H A P T E R 2 
I D E N T I F I C A T I O N O F O C A - B T A R G E T G E N E S 
I N V O L V E D I N A N T I G E N - D E P E N D E N T B C E L L 
D I F F E R E N T I A T I O N 
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2.1 P R E F A C E : A D D I T I O N A L O C A - B T A R G E T G E N E S ? 
Oca-br/- mice have the striking inability to form germinal centers and B 
cells from these mice show diminished proliferation in response to B cell 
receptor (BCR) ligation (Kim et al., 1996; Schubart et al., 1996; Nielsen et 
al., 1996), indicating that OCA-B regulates additional target genes that 
function in B cell signaling pathways leading to proliferation and 
germinal center formation. Consistent with a role for OCA-B in mature B 
cell function, the level of OCA-B is tightly regulated during B cell 
activation and germinal center formation, both transcriptionally and 
post-transcriptionally (Qin et al., 1998; Stevens et al., 2000; Tiedt et al., 
2001; Boehm et al., 2001). Apart from Ig promoters and the IgH 3' 
enhancer, the octamer-containing promoters in the BLR-1, PU.l, and 
IgP/B29 genes were reported to be activated by OCA-B in transient 
transfection assays (Chen et al., 1996; Wolf et al., 1998; Malone and 
Wall, 2002). However, reduced expression of these genes does not fully 
account for the immune defects observed in Oca-br/- mice. Therefore, 
identification of additional OCA-B target genes was expected to reveal 
genes that play critical roles in antigen-dependent B cell differentiation 
events including the germinal center formation. This portion of the study 
(done in collaboration) used cDNA microarrays to identify genes that are 
up-regulated upon stimulation of normal resting splenic B cells through 
the BCR alone or through BCR and helper T cell (Th) co-stimulation. 
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Additional studies then identified genes that are under-stimulated in 
Oca-b/-B cells in response to these signals. 
2.2 RESULTS 
OCA-B Expression Profile During B Cell Activation 
As mentioned previously, OCA-B is up-regulated in activated B cells (Qin 
et al., 1998). To characterize OCA-B induction further, we activated 
resting splenic B cells for up to 94 hours using BCR ligation or co-
stimulation. OCA-B expression levels were analyzed in cells stimulated 
with anti-IgM alone or with a combination of anti-IgM, anti-CD40, and 
IL-4 for 16, 24, 45, 70, and 94 hours by immunoblot (Figure 2.2.1). 
OCA-B levels were highly up-regulated after 45 hours of stimulation with 
anti-IgM. During co-stimulation, the OCA-B level is up-
regulated faster and to a greater degree than for anti-IgM stimulation. 
When stimulated with BCR alone, the OCA-B level decreased to that of 
the resting state by the 94 h point. However, the OCA-B level persisted 
and increased through the late time points during BCR/Th co-
stimulation. These results indicate that OCA-B expression is 
differentially regulated by BCR alone and co-stimulation, and that OCA-
B is likely to play a role in both early and late stages of antigen-
dependent B cell development. The following cDNA array studies focused 
on time points at which OCA-B level was high. 
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Figure 2.2.1 Immunoblot Analysis of OCA-B Expression 
0 16 24 45 70 94 h 
Anti-IgM 
Anti-IgM & 
Anti-CD40 
Anti-IgM, 
Anti-CD40 & 
IL-4 
OCA-B 
ERK 
OCA-B 
ERK 
OCA-B 
ERK 
Resting B cells were stimulated with anti-IgM, anti-IgM a n d 
anti-CD40 or anti-IgM, anti-CD40, a n d IL-4. W h o l e cell 
extracts were m a d e at the indicated time points a n d the 
expression of O C A - B w a s monitored by immunoblotting. 
E R K expression w a s monitored for normalization. 
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G e n e Expression Profiles in Response to Signaling 
After determining conditions for the optimal up-regulation of OCA-B, this 
information was used to analyze gene expression profiles through cDNA 
microarrays. We reasoned that since the OCA-B level was very low in 
resting B cells and highly up-regulateed after stimulation (Figure 2.2.1), 
OCA-B target genes should also be up-regulated in a similar pattern. 
However, there are a substantial number of other transcription factors 
that are up-regulated by these types of stimulation. Therefore, only a 
fraction of the up-regulated genes would be targets of OCA-B. In order to 
obtain an appropriate data set, we reasoned that when Oca-b/- cells are 
stimulated with the same conditions, only those pathways that require 
OCA-B would be under-stimulated, whereas OCA-B independent 
pathways would be preserved. Thus a comparison of up-regulated genes 
in wildtype (activated/resting) and Oca-b/- (activated/resting) was 
expected to result in the identification of genes that require OCA-B for 
expression. This approach has an advantage over a direct comparison of 
gene expression profiles (activated wildtype/activated Oca-b/) because 
any populational and developmental differences in gene expression 
patterns between the two genotypes would be normalized. Thus, any 
differences that we identify in gene expression profiles would represent 
differences caused by the absence of OCA-B. 
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W e analyzed the gene expression profile of wild-type B cells after 45h of 
BCR stimulation (high OCA-B expression). This analysis showed 180 up-
regulated genes and 80 down-regulated genes by 2 fold or greater. We 
then wanted to identify genes that were up-regulated by at least 2 fold in 
the BCR stimulated wildtype cells (Figure 2.2.2). Of this class, many 
genes were involved in cell cycle, proliferation, signaling, and 
transcription (Figure 2.2.2). This indicates that the length of stimulus 
was appropriate and that the cells are still proliferating. Based on 
previous reports, the data is consistent with a B cell activation 
phenotype. The genes up-regulated with BCR stimulation included cyclin 
D2 and CD44 (Figure 2.2.2), which have been identified as B cell 
activation markers in published microarray analyses (Alizadeh et al., 
2000; Glynne et al., 2000; Shaffer et al., 2001). Furthermore, many of 
the identified genes have previously been found to be induced in 
stimulated B cells using various techniques, including the small 
inducible cytokine subfamily A member 22 [Abcd-1) (Schaniel et al., 
1998), neurogranin (Glynne et al., 2000), Lck (Glynne et al., 2000; Taieb 
et al., 1993), pre-B cell colony enhancing factor {Pebfi (Dadgostar et al., 
2002), Ki67 (Dadgostar et al., 2002), Ezh2 (Raaphorst et al., 2000) and 
transferrin receptor (Kvaloy et al., 1984). These observations suggest 
that the B cell activation system used for these experiments is 
physiologically meaningful and that the cDNA microarray analyses have 
the potential to give valid OCA-B target genes. For the comparison of 
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Figure 2.2.2 G e n e s Induced b y B C R Stimulation 
Cydin D 3 
Acdpl 
Gsptl 
Cdc20 
Cdc37 
Cksl 
Bcl212 
CD27bp 
Lekl 
Stathmin 
Ki67 
TransfR 
Ode 
Srm 
Npml 
Mcra4 
Rpa2 
H2A.1 
Primase 1 
dUTPase 
Pcna 
Lck 
SlOOalO 
PpplrHb 
Ppp2ca 
Cacybp 
Neurogran 
Ywhae 
CD44 
Kcnn4 
S6 kinase 
L12 
L7 
Fibrillarin 
eIF-4A 
eIF-4E 
eIF-2A 
Hpla 
DbpA 
Trim28 
Ezh2 
Hmg-2 
Hmg-Y 
Paf67 
Rpa40 
Genes whose expression level increased at least 2 fold after 45h of 
B C R stimulation were identified using c D N A array analyses and 
grouped according to function. O C A - B target genes are s h o w n in 
boldface. 
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W T vs. Oca-b/- cells, w e analyzed gene expression profiles from 45h of 
BCR stimulation and 21h, 45h, and 92h of co-stimulation, coincident 
with increasing OCA-B expression (Figure 2.2.1). 
Genes that are Under-Expressed in Oca-Tar/- B Cells 
To identify genes that require OCA-B for activation-induced up-
regulation, expression profiles in Oca-b/- B cells were analyzed before 
and after activation. A majority of the genes that were up-regulated in 
wildtype B cells were also up-regulated in Oca-b/- B cells, indicating that 
the overall transcription status of Oca-b/ B cells is intact. The identified 
genes were under-stimulated in knockout B cells by at least two-fold 
after activation in three replicate experiments and some of these genes 
are shown in bold of Figure 2.2.2. Thus, OCA-B appears to act on a 
restricted set of genes that play critical roles in B cell activation and 
differentiation (Table 2.2.1, first two columns). Also, the phenotype of 
Oca-b/- mice was reflected in these experiments, in that the array data 
revealed a reduction of IgGl expression in the knockout B cells upon 
activation (Figure 2.2.3). Furthermore, the array data was validated by 
both quantitative PCR (QPCR) and Northern blotting, indicating a false 
positive rate of 5%. OCA-B dependent genes were confirmed using both 
of these methods (Table 2.2.1). In general, the levels of induction 
observed with the Northern and QPCR were greater than those observed 
in the cDNA array analysis (Table 2.2.1). This tendency has been 
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Figure 2.2.3 IgGl Expression after Co-stimulation is Reduced in 
Oca-b*'" B Cells 
BCR&Tb-21h BCR&Th-42h BCR&Th-%h 
Induction of IgGl (AI843944) expression upon co-stimulation in 
Oath*'* and Qcobbr/~ cells was determined by c D N A array 
analyses. The average fold induction levels from five replicate 
experiments are shown. 
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reported before and m a y reflect the differences in kinetics of 
hybridization between solid-state- and solution-based reaction conditions 
(Taniguchi et al., 2001; Wurmbach et al., 2001). 
Among the genes induced by BCR ligation, those encoding the protein 
tyrosine kinase LCK, potassium intermediate calcium-activated 
conductance channel (KCNN4), CDC37 and Cyclin D3 failed to be up-
regulated in Oca-b/- B cells (Table 2.2.1 and Figure 2.2.4). The 
mammalian homolog of yeast CDC37 is a molecular chaperone that 
targets HSP90 to cyclin-dependent kinase 4, making it a key regulator of 
cell cycle progression (Chen et al, 2002). LCK is a tyrosine kinase 
originally identified in T cells but has also been implicated in B cell 
proliferation and lymphomagenesis (Jucker et al, 1991; Allen et al, 
1992; Wildin et al, 1995; Von Knethen et al, 1997). Interestingly, the 
Lck gene contains two promoters that are used in a developmental- and 
cell-type-specific manner: a proximal promoter that is active in 
thymocytes and a distal promoter that is active in mature T and B cells 
(Wildin et al., 1995). Multiple studies have shown that the potassium 
channel KCNN4 is up-regulated in activated T cells and is required for 
sustained T cell activation by promoting Ca2+ influx (Khanna et al., 1999; 
Ghanshani et al., 2000). Cyclin D3 has been shown to be up-regulated 
in activated B cells (Solvason et al., 1996) and functions as a positive 
regulator of cyclin-dependent kinases 4 or 6, whose activity is required 
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Figure 2.2.4 Analysis of OCA-B-dependent G e n e Expression 
by Northern Blot 
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A. Expression of the O C A - B target genes were analyzed in cells that 
had been stimulated with anti-IgM for 45 hours. B. Expression of the 
O C A - B target genes were analyzed in cells that had been stimulated 
with anti-IgM for 45h or anti-IgM, anti-CD40, and IL-4 for u p to 96 
hours. C. Expression of the O C A - B target genes were analyzed in cells 
that had been activated with co-stimulation for u p to 96 hours. The 
values s h o w n below the blots are normalized fold changes relative to 
the resting state (0). Target gene levels were normalized against 18S 
rRNA. A negative fold change denotes down-regulation. 
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for the Gi/S transition. It is expected that the genes encoding these 
proteins contribute to the BCR-mediated defects observed in Oca-b/- B 
cells. 
Northern blotting showed that Cdc37 and Lck are under-stimulated in 
Oca-b/- B cells upon activation with a BCR stimulus (Figure 2.2.4a). Two 
genes have particularly interesting patterns of regulation when 
comparing wildtype versus Oca-b/- B cells. SI00a 10 (calpactin) is 
sharply down-regulated throughout the co-stimulation time course in 
wildtype cells; whereas it is regulated less strongly in knockout cells 
(Figure 2.2.4b). The EF-hand family member, S100A10, is a structural 
protein involved in Ca2+ dependent membrane organization (Ruse et al, 
2001; Gerke and Mosse, 2002). Also, the Kcnn4 gene, which encodes a 
calcium-activated potassium channel, is significantly under-regulated in 
Oca-b-/- B cells after BCR activation. In sharp contrast, Kcnn4 is up-
regulated at later time points of co-stimulation only in the knockout cells 
(Figure 2.2.4b). Therefore, OCA-B seems to play dual roles, contingent 
on the signaling pathway activated, in the regulation of these two genes. 
Namely, OCA-B is required both for their up-regulation by BCR and for 
their down-regulation by Th co-stimulation (see Discussion). In addition 
to Ig genes, this work has identified other OCA-B-dependent genes that 
are induced by co-stimulation signals (Table 2.2.1 and Figure 2.2.4). 
These include pl,4-galactosyltransferase (B4galtl), which is involved in 
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glycosylation of m a n y immunologically important molecules such as IgG 
(Rudd et al. 2001), and a recently identified CD20-related 
transmembrane protein termed membrane-spanning 4-domains 
subfamily A member 11 (Ms4all or Ms4a6b) (Ishibashi et al, 2001; 
Liang and Tedder, 2001). These genes showed significantly reduced 
induction by co-stimulation in Oca-b/- B cells and are likely to be 
involved in critical T-dependent B cell functions that are defective in Oca-
br/- mice. 
Direct Regulation of OCA-B Target Genes 
Some of the OCA-B-dependent genes identified by these experiments are 
likely to contain binding sites for an OCT/ OCA-B complex in their 
promoters and/or enhancers and, thus, directly require OCA-B for full 
transcriptional activity. Others might be downstream, making them 
indirect targets of OCA-B. Indeed, database searches using TESS 
(transcription element search software www.cbil.upenn.edu/tess) 
indicated that some of these genes have upstream octamer elements, 
including both the distal promoter of Lck and the predicted promoter 
region of Kcnn4 contain (Figure 2.2.5a). We analyzed the occupancy of 
these sites by OCT and OCA-B in the murine lymphoblastic B cell line 
A20 by chromatin immunoprecipitation assays. OCA-B and OCT-2 were 
found to bind specific octamer sites on the Lck (-396) and Kcnn4 (-2932) 
promoter regions (Figure 2.2.5b). To verify this finding we also performed 
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Table 2.2.1 Verification Table to S u m m a r i s e the Fold Induction of 
O G A » B Target G e n e s 
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Northern blotting and Q P C E were used to verify the data set 
obtained through c D N A array analyses, nd, not determined 
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Figure 2.2.5 Identification and Occupancy of Octamer Elements 
within OCA-B Target Gene Promoter Regions 
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A. The octamer elements identified on the Lck- and Kcnn4-promoter 
regions and their positions relative to the transcriptional start site 
are shown. The A/T residue that is critical for O C A - B binding is 
underlined. The transcriptional start site for Kcrm4 is estimated 
based on the E S T clone and m o u s e genome alignment 
(www.ncbi.nlm.nih.gov). B. Chromatin immunoprecipitation assays 
were performed using the nuclei isolated from A 2 0 cells. C. 
Identification of octamer elements within the putative regulatory 
regions of other O C A - B target genes. 
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the experiments in primary B cells freshly isolated by F A C S (data not 
shown). The occupancy of these sites by OCT-2 and OCA-B was 
confirmed (data not shown). Octamer elements were located within the 
predicted promoter and enhancer regions of several of the other OCA-B 
target genes identified by the microarray analysis; however, the 
occupancy of these sites by OCA-B will need to be examined (Figure 
2.2.5c). 
Expression Patterns of OCA-B Target Genes 
Since many of the genes found to be regulated by OCA-B play a role in 
cellular proliferation and signaling, they may be candidates to explain 
the severe defects observed in Oca-b/- mice. However, the B cell-specific 
functions of these target genes such as Kcnn4, Lck, Cdc37 and Cyclin D3 
are relatively uncharacterized. The first step toward understanding how 
the regulation of these genes may contribute to the Oca-b/' phenotype 
was to profile their expression patterns in sorted primary B cells (this 
also will ensure that cells are live and free of contaminating populations) 
(Figure 2.2.6). Primary B cells at various stages of development were 
collected by FACS from spleens of wildtype mice. Germinal center B cells 
were collected from DNP-KLH-immunized mice from the IgM+/IgD/PNA+ 
compartment (Figure 2.2.6a). Plasma cells were collected from the B220" 
/CD138+ compartment and found by RT-PCR, as expected, to have 
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Figure 2.2.6 F A C S to Collect Cells for G e n e Expression Analysis 
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Various stages of splenic B cells from Wildtype and Oca-b'/- mice 
were collected by flow cytometry based on expression of key cell 
surface markers. A. Mature, activated and germinal center B cells 
were collected based on display of IgM, IgD, and PNA. In order to 
increase the percentage of germinal center cells, the mice were 
immunized with D N P - K L H . With the exception of the absence of a 
germinal center fraction, the overall profiles were similar for the Oca-
b'/' mice (not shown). 
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Figure 2.2.6- C o n t i n u e d 
B. Plasma Cell Sort 
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P C R for BLIMP-1 w a s performed using material from the cellular 
fractions s h o w n in panel B. 
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elevated expression of Blimp-1 (Figure2.2.6b). BLIMP-1 is a 
transcriptional repressor that is critical for plasma cell differentiation 
and has been found to be up-regulated early in this differentiation 
process (reviewed in Johnson et al., 2005). Post-sort analysis showed 
that all of the sorted populations were at least 92% pure (Figure 2.2.6). 
Interestingly, OCA-B expression peaked in activated B cells (IgM+/IgD+), 
which included the earliest stage of germinal center cells 
(IgM+/IgD+/PNA+) (Figure 2.2.7a). RT-PCR indicated that the OCA-B 
target genes analyzed, Cdc37, Cyclin D3, Kcnn4 and Lck are all expressed 
and regulated throughout mature B cell development (Figure 2.2.7b). 
Furthermore, quantitative PCR for Lck, Kcnn4, and Cdc37 revealed a 
significant reduction in transcription of these genes in Oca-br/- activated 
(IgM+/IgD+) B cells isolated by flow cytometry (Figure 2.2.8). This finding 
corresponds well with our data from similar experiments with ex vivo 
activated B cells as well as with a recently published report that the 
number of KCNN4 channels increases sharply with B cell activation and 
that blockage of the this channel causes reduced B cell proliferation 
(Figure 2.2.4; Wulff et al., 2004). There were also significant reductions 
in the expression of the target genes in Oca-b/- plasma cells. 
Interestingly, we also observed up-regulation of Kcnn4, Lck, and Cdc37 in 
the Oca-b-/- mature B cell fraction (IgM+/IgD) (Figure 2.2.8). Similarly, 
up-regulation of SlOOalO and Kcnn4 was observed by Northern blotting 
in Oca-b-/- B cells that had been stimulated with anti-IgM, anti-CD40, 
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Figure 2.2.7 Expression Pattern of OCA-B and its Target Genes 
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A. Whole cell extract was prepared from the collected fractions 
(Figure 2.2.7) and used for Western blotting. B. The expression 
patterns of OCA-B target genes were examined by RT-PCR and 
normalized by Gapdh. The exponential phases of the reactions were 
determined by QPCR. 
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Figure 2.2.8 O C A - B Target G e n e Expression 
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Q P C R w a s performed using R N A from primary cells (Figure 2.2.6). The 
expression levels of the O C A - B target genes were monitored. T h e 
values s h o w n were determined by relative quantification using G a p d h 
and are averages from at least three replicates. 
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and IL-4 (Figure 2.2.4b). These data indicate that O C A - B might also 
activate expression of a negative regulator of these genes. 
Although we had observed changes in gene expression in freshly isolated 
Oca-b/- B cells, the sorting scheme applied in Figure 2.2.6 broadly 
groups Tl (Transitional B cells of Type 1) and MZ (Marginal Zone) B cells 
into the IgM+/IgD" fraction and T2 (Transitional B cells of Type 2) and 
Mature B cells into the IgM+/IgD+ fraction. In order to analyze the 
expression of OCA-B target genes in more detail, we performed a finer 
separation of these cell types. Surface expression of IgM, IgD, and CD21 
can be used to separate splenic Tl, T2, MZ, and Mature B cells (Figure 
2.2.9a and Carsetti et al., 1995; Loder et al., 1999). Interestingly, the 
Oca-br/- mice had a severe reduction in the MZ compartment (IgM+IgD-
CD21+) (Figure 2.2.9a), despite previous reports that this phenotype is 
not prevalent on the 129 X C57BL/6 background (Samardzic et al., 
2002). Nevertheless, we collected MZ cells from wildtype mice and Tl, T2 
and Mature B cells from both genotypes for use in gene expression 
studies. There was a significant reduction of Kcnn4 gene expression in 
Oca-b/- mature B cells, which coincides with a high level of OCA-B 
expression in the wildtype mature B cells (Figure 2.2.9b). Therefore, it is 
possible that decreased levels of KCNN4 might contribute to the defective 
differentiation and function of Oca-b'/- mature B cells. Although we have 
a substantial amount of data to indicate that Lck is an OCA-B target 
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Figure 2.2.9 Target G e n e Expression in Oca-b*'* a n d Oca4tf' 
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Q P C R . Performed as described for Figure 2.2.8. 
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gene (Figures 2.2.4a, Figure 2.2.5, Figure 2.2.8, and Table 2.2.1), w e did 
not observe decreased expression in any of the Oca-br/- B cell subsets 
collected by this sorting scheme (Figure 2.2.10b). Because LCK is not 
regulated by OCA-B in mature, MZ, Tl or T2 B cells, it is possible that 
regulation of LCK by OCA-B is more critical in early B cells or in 
activated B cells; therefore, we examined LCK protein levels in ex vivo 
cultured B cells that were activated in culture with anti-IgM or anti-IgM, 
anti-CD40, and IL-4 co-stimulation. Consistent with previous 
experiments that examined the LCK RNA level, the LCK protein level is 
reduced in Oca-b/- cells that have been activated with anti-IgM but not 
with co-stimulation (Figure 2.2.4, Figure 2.2.10), indicating that LCK is 
an OCA-B target gene at distinct phases of B cell development and 
activation. Furthermore, immunohistochemistry indicates that LCK is 
highly expressed at the germinal center and, as expected, this staining 
pattern is absent in Oca-b/- mice, which lack germinal centers (Figure 
2.2.11). 
Regulation of LCK Expression by OCA-B 
To further examine the regulation of LCK expression by OCA-B, we 
performed transfection assays in Hela and 293T cells with a reporter 
containing the distal Lck promoter, which has a higher activity in B cells 
than the T cell-specific proximal promoter (Wildin et al., 1995). Co-
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Figure 2.2.10 Analysis of L C K Protein Levels in Activated B Cells 
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transfection of an O C A - B expression vector caused a sharp increase in 
Lck promoter activity, which could not be generated by OCT-2 co-
transfection (Figure 2.2.12). Furthermore, OCA-B functions in 
conjunction with the endogenous OCT-1 or with transfected OCT-2 to 
regulate LCK expression (Figure 2.2.12). 
Not only is Lck likely to be an important OCA-B target gene, but Oca-b/-
and Lck-/- mice may have partially overlapping phenotypes related to BCR 
signaling and Bla cell development. As mentioned previously, Oca-br/-
mice not only have defective BCR signaling and impaired TD immune 
responses also an enhancement of peritoneal Bla cells, a unique B 
cell subset that is involved in natural immunity (Kim et al., 2000). 
However, there have been conflicting reports as to the nature and extent 
of B cell-specific defects in Lck-/- mice (Ulivieri et al., 2003; Dal Porto et 
al., 2004; Frances et al., 2005). For these reasons it was important to 
further analyze B cell development in Lck-/- mice (obtained from Tak Mak) 
in order to determine the significance of LCK regulation by OCA-B. 
Unfortunately we were unable to identify any defect by flow cytometry in 
early B cell or plasma cell development using well-defined markers such 
CD25, CD43, CD117, CD138, B220 and IgM (Data Not Shown). Of note, 
we observed the recently reported defect in plasma cell (CD138high/B220) 
differentiation of Oca-br/- mice (Data Not Shown; Corcoran et al., 2005). 
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Figure 2.2.12 Analysis of L c k Distal Promoter D e p e n d e n c e o n 
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A. The responsiveness of the Lck distal promoter to O C A - B a n d O C T -
2 w a s analyzed in HelaS or 293T cells that had been transiently 
transfected using Lipofectamine or Fugene reagents with a n Lck 
distal promoter-luciferase vector, a n O C A - B - C M V expression vector, 
and/or an O C T - 2 - C M V expression vector. P R L - C M V w a s used to 
normalize the luciferase activity. 
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Lck-/- mice displayed an enhancement in the M Z and Tl compartments 
(Figure 2.2.13); however, this finding is most likely linked to defective T 
cell-dependent B cell activation caused by the absence of mature T cells 
in Lckr/- mice (Molina et al., 1992) and is unlikely to be a B cell 
autonomous defect. Because Oca-b/- mice have the opposite phenotype 
of Lck-/- mice, namely a decrease in MZ and Tl cells (Figure 2.2.13; 
Samardzic et al., 2002; Jankovic et al., 2003), we focused on the similar 
increase of peritoneal Bla cells in both Lckr/- and Oca-b'/ mice (Figure 
2.2.14). This finding suggests that regulation of LCK expression by OCA-
B might be an important factor in Bla cell development. To examine this 
possibility, wildtype and Oca-b/- peritoneal Bla cells were sorted and 
cultured with anti-IgM or anti-IgM and IL-4 for 48 hours after which 
protein levels of LCK were examined by immunoblot (Figure 2.2.15). 
Under both activation conditions, Oca-br/- cells have significant 
reductions in LCK protein levels, which coincides with a reduction in 
tyrosine phosphorylated proteins (pTYR) (Figure 2.2.16). Similar results 
were also obtained when cells isolated by MACS were used (Data Not 
Shown). These data indicate that like conventional B2 cells, Oca-b/- Bla 
cells also have compromised BCR signaling. 
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Figure 2.2.14 Analysis of B l a cells in Oca-b'' a n d Lck'' m i c e 
W T Lck Oca-b 
43.8 
29.6 36.5 
Cells from the peritoneum of W T , Lck:'-, and O c a b ' ' mice were 
harvested and Bla cells were analyzed based o n surface expression 
of IgM, C D lib, and C D 5. 
59 
Figure 2.2.15 FA C S to Collect Bla Cells for Gene Expression Analysis 
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The indicated fractions were collected by F A C S based on surface 
expression of IgM and CDllb/Macl from the spleens of Ocarb*/* 
(shown) and Oca-b-/- mice. B. Post-sort analysis of the sorted 
IgM+Macl+ Bla population. 
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Figure 2.2.16 Analysis of L C K Protein Levels in Activated B Cells 
Oca-b*" Oca-br'' 
L C K 
E R K 
PTyr 
Oca-b*/* or Oca-br'- sorted Bla cells (Figure 2.2.16) were activated in 
culture with anti-IgM F{ab')2 fragment or with anti-IgM Ffab*^ 
fragment and IL-4 for 48 hours. The expression of L C K , E R K , and 
tyrosine phosphorylated proteins (pTYR) w a s analyzed by 
immunoblot. 
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2.3 DI S C U S S I O N 
Gene Expression Profiles in Normal B Cells 
One aim of this study was to identify OCA-B target genes that are 
associated with B cell activation and maturation processes. To this end, 
we used a B cell culture system that allows stimulation by the BCR. 
Previous studies showed that resting splenic B cells cultured in the 
presence of an anti-IgM-derived F(ab')2 fragment at 25-30 [ig/ml induces 
a burst of cell proliferation that peaks around 48-72 h (Defranco et al., 
1982; Kim et al., 1996). Therefore, this culture system likely mimics the 
activation process that accompanies a BCR-antigen interaction. 
Accordingly, the gene expression profiles showed that B cells stimulated 
with anti-IgM for 45 h up-regulated transcripts of many genes involved in 
cell cycle progression, DNA replication and repair, cell proliferation, 
translation, and transcription. This finding clearly demonstrates that B 
cells are actively proliferating and making new transcripts and proteins. 
Interestingly, this is the time period when the BCR-induced OCA-B level 
is maximal, indicating that OCA-B is involved in the B cell expansion 
phase. Most of the genes involved in cell cycle regulation, DNA 
replication and repair, cell proliferation, transcription, and translation 
induced by BCR ligation were also induced by co-stimulation but at an 
earlier time point (21 h vs. 45 h). The fact that OCA-B is expressed at 
early (21 h) as well as late (45-96 h) time points during co-stimulation 
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again indicates O C A - B involvement in the expansion, as well as the 
functional phase of antigen-dependent B cell differentiation. 
Identification of OCA-B-Dependent Genes 
This study has allowed identification of additional OCA-B target genes, 
such as CyclinD3, Cdc37, Kcnn4, and Lck, that are up-regulated in 
response to BCR ligation and likely to be involved in B cell proliferation 
and signaling. Additionally, B4galt4 and Ms4a6b (Ms4all) are 
downregulated in Oca-b-/- B cells that have been given Th co-stimulation. 
Because glycosylation is involved in a wide range of important processes 
(Rudd et al., 2001), defective glycosylation would have a significant 
impact on B cell function. Notably, the B4galt4 activity is regulated 
primarily at the level of transcription (Lemaire et al., 1998). Although the 
function of Ms4a6b (Ms4all) is currently unknown, the fact that it 
contains transmembrane domains that are conserved in CD20, HTM4, 
and the high-affinity IgE receptor |3 chain, suggests an involvement in 
signal transduction (Liang and Tedder, 2001; Ishibashi et al., 2001). 
Interestingly, OCA-B appears to be involved both in downregulation and 
in up-regulation of Kcnn4 and SlOOalO. S100A10 (or calpectin) is a 
subunit of anexin 2, which is involved in Ca2+-mediated lipid raft 
organization and vesicle movement (Gerke and Moss, 2002). The fact that 
SlOOalO and Kcnn4 are up-regulated by BCR ligation and down-
regulated by Th co-stimulation suggests that while they function in BCR-
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induced expansion, they are not required for the functional phase of B 
cell differentiation. It also is possible that the failure to down-modulate 
these genes in Oca-b/- B cells during the functional phase (i.e., BCR+Th, 
45-96 h) may have inhibitory effects on B cell differentiation. Because 
OCA-B seems to be involved in both positive and negative regulation of 
the same genes, depending on the signaling pathway, it is an intriguing 
possibility that OCA-B may activate negative regulators of these genes. 
Furthermore, the direct OCA-B target gene, Lck has also been implicated, 
but not conclusively shown, to be involved in Bla cell development and 
cell signaling (Ulivieri et al., 2003; Dal Porto et al., 2004; Frances et al., 
2005). Given that Oca-b/- mice also show an enhancement of Bla cells 
(see Results; Kim et al., 2000) it will be important to determine the 
functional significance of LCK regulation by OCA-B. Nevertheless, this 
study has led to the identification and confirmation of direct OCA-B 
target genes, which may prove to be important for the differentiation and 
function of multiple B cell subsets. In conclusion, this study has 
identified genes involved in B cell proliferation and signaling as targets of 
OCA-B. Considering that the ability to proliferate and accurately process 
BCR- and Th-derived signals is critical for antigen-driven B cell 
differentiation, including the germinal center reaction (MacLennan et al., 
1992), failure to appropriately regulate these genes provides a possible 
explanation for the severe defects observed in Oca-br I- mice. 
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C H A P T E R 3 
T H E R O L E O F O C A - B I N E A R L Y B C E L L 
DEVELOPMENT AND PRE-BCR 
SIGNALING 
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3.1 P R E F A C E : OCA-B F U N C T I O N IN PRE-B C E L L S ? 
As mentioned previously, studies with Oca-b knockout mice (Oca-b'/') 
showed that OCA-B plays a broad role in B cell development and 
function (Kim et al. 1996, Schubart et al., 1996, Nielsen et al. 1996). The 
most drastic defect in Oca-b'/- mice is observed in the peripheral 
lymphoid organs during antigen-dependent B cell maturation and 
effector function. These defects include dramatically diminished levels of 
IgH secondary isotypes, a complete lack of germinal centers in the 
lymphoid organs, and impaired antibody responses to both T-
independent and T-dependent antigens (Kim et al. 1996, Schubart et al., 
1996, Nielsen et al. 1996, Kim et al., 2000). The reduction in secondary 
isotype levels is caused by reduced expression of the switched genes and 
may be attributed in part to OCA-B function at the 3' enhancer (Kim et 
al., 1996; Tang and Sharp, 1999; Stevens et al., 2000). Surprisingly, IgM 
expression is largely normal in Oca-b/- mice, although OCA-B is required 
for full activity of a subset of k light chain promoters (Vk4 and Vk3-83) 
(Casellas et al., 2003). There is also a reduction in the transitional B cell 
compartment in the spleens of Oca-br/- mice, perhaps as a consequence 
of the skewed IgK repertoire and/or a B cell signaling defect (Casellas et 
al., 2003, Janovic and Nussenzweig, 2003). 
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At the cellular level Oca-b/' B cells are deficient in processing B cell 
antigen receptor (BCR)-derived signals, as evidenced by their reduced 
proliferation following BCR ligation and an increased number of 
immature, apoptotic B cells in the bone marrow of Oca-b'/- mice (Kim et 
al., 1996; Hess et al., 2001). A recent study (see Chapter 2) has 
identified additional OCA-B target genes (e.g. Kcnn4, Lck, Cyclin D3, and 
Cdc37) that may be involved in these processes (Kim et al. 2003), 
although the exact mechanisms by which these genes contribute to B cell 
signaling and differentiation are not fully understood. Additionally, OCA-
B is likely to play a unique role in B cell signaling as evidenced by the 
presence of two distinct OCA-B isoforms, one that is predominantly 
nuclear and another that is myristoylated and present in the cytoplasm 
(Yuetal., 2001). 
Given that Oca-b/- B cells are deficient in BCR signaling, it seemed 
important to determine whether these cells have a similar phenotype 
relative to pre-BCR signaling. This is a particularly interesting possibility 
since pre-BCR and BCR signaling pathways involve the action of many of 
the same proteins such as SYK, PLCy2, FYN, BLK, LCK and LYN 
(reviewed in Wang and Clark, 2003). Furthermore, IgP, which is the 
signaling component of both the pre-BCR and BCR, has been identified 
as an OCA-B target gene in mature B cells (Malone and Wall, 2002). 
Additionally, and significantly, the signaling proteins BTK and SLP-65, 
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which are also critical for B C R signaling and mature B cell 
differentiation, have recently been shown to play a role in early B cell 
development as well (Middendorp et al., 2002; Flemming et al., 2003; 
Kersseboom et al., 2003; Hendriks and Middendorp, 2004). Further 
supporting its role in pre-BCR signaling, OCA-B is highly expressed in 
large B220+IgM- pre-B cells (Qin et al., 1998), which includes pre-BCR 
expressing cells (reviewed in Hendricks and Middendorp, 2004). 
Additionally, the OCA-B promoter was shown to be active in transiently 
transfected pre-B cell lines that also had endogenous OCA-B expression 
(Stevens et al., 2000). 
3.2 RESULTS 
The Effect of OCA-B Deficiency on Early B Cell Development 
In order to identify possible defects in early B cell development in Oca-b/-
mice, our first goal was to characterize the distribution of bone marrow B 
cell populations using flow cytometry (Figure 3.2.1). Because Oca-b/- B 
cells have a compromised response to BCR signaling, we were 
particularly interested in analyzing cell stage transitions correlating with 
changes in pre-BCR expression. For this purpose, and to dissect the pre-
B cell compartment of wildtype and Oca-b/- mice, we examined the 
expression patterns of cell surface markers such as B220, IgM, CD43, 
CD 117 and CD25. The knockout mice appear to have a partial 
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developmental block between the pre-B 1 and pre-B2 cell stages. This is 
mainly indicated by a reproducible decrease (40-50%) in the 
B220+/CD25+ pre-B2 cell compartment and an increase of at least two-
fold in cells at the preceding developmental stage (B220+/CD43+). A 
partial block is consistent with previous findings, in that a substantial 
number of B cells are able to reach maturity despite an overall reduction 
of peripheral B cells (Schubart et al., 1996). Consistent with an 
increased proportion of B220+/CD43+ pre-B cells in Oca-b/' mice, there 
was also a significant increase (on average 25%) (p=0.018) in large cells 
(high FSC) within the bone marrow (Figure 3.2.1b, left panel). This 
increase in large cells was also apparent when examining the B220+ 
compartment (p=0.012), where there was a similar increase of large cells 
relative to wildtype (Figure 3.2.1b, right panel). In addition, there was 
also a 40-50% decrease in B220med/[A+ cells in the Oca-b'/' mice (9% vs. 
5.4%) (Figure 3.2.1a). As previously reported (Schubart et al., 1996; 
Hess et al., 2001), Oca-b'/' mice also had a significant reduction in 
B220hishIgD+ re-circulating B cells (5.6% vs. 1.6%) (Figure 3.2.1a). 
Overall, these findings suggest that OCA-B deficiency results in reduced 
developmental progression of B cells into the B220med/CD43/CD25+ pre-
B2 compartment, which in turn leads to a build up of cells in the 
B220+/CD43+/CD25- pre-Bl compartment. This defect could be 
attributed not only to a potential defect in pre-BCR signaling but also to 
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Figure 3.2.1 Oca-b' M i c e H a v e a n Altered Distribution of B o n e 
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A. Cellular populations from Ocarb*'* and Oca-b7 bone marrow were 
analyzed by flow cytometry using antibodies against cell surface 
markers, as labeled. The n u m b e r s within the gates are percentages of 
live cells (low SSC). Data are representative of three experiments. 
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Figure 3.2.1- C o n t i n u e d 
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B. Size analysis of live cells (left) or B220+ cells (right) from bone 
marrow of Oca-b*'* (red) or Oca-br/- (blue) mice. 
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the function of the newly identified O C A - B target genes that include 
Cdc37, Cyclin D3, Kcnn4, and Lck (Chapter 2; Kim et al., 2003). 
Analysis of Newly Identified OCA-B Target Genes 
Many of the recently identified OCA-B target genes play a role in cellular 
proliferation and signaling, making them candidates for explaining the 
severe defects observed in Oca-b''- mice. However, the B cell-specific 
functions of target genes such as Kcnn4, Lck, Cdc37 and Cyclin D3 are 
relatively uncharacterized. The first step toward understanding how the 
regulation of these genes might contribute to early B cell development 
was to profile their expression patterns in primary B cells. Early B cells 
from the bone marrow of wild type mice were fractionated by FACS based 
on surface expression of B220 and CD43 (Figure 3.2.2). The populations 
analyzed included non-B cells (B220/CD43+), pro-B cells 
(B220duU/CD43+), pre-B cells (B220med/CD43"), and immature B cells 
(B220hish/CD43+) (Figure 3.2.2a). Post-sort analyses showed that all of 
the sorted populations were of sufficient purity (Figure 3.2.2). The OCA-
B protein level was highest in bone marrow B cells at the pre-B cell 
stage, as evidenced by immunoblot (Figure 3.2.3c). Interestingly, the 
OCA-B protein level in pre-B cells was nearly equivalent to the amounts 
typically observed in activated (IgM+/IgD+) splenic B cells (data not 
shown). The expression patterns of OCA-B target genes Cdc37, Cyclin 
D3, Kcnn4, and Lck were analyzed by RT-PCR and Western blotting 
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Figure 3.2.2 F A C S to Isolate B o n e M a r r o w B Cells 
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Bone marrow B cells were collected by F A C S based o n B220 and C D 4 3 
surface marker expression. Pi-negative cells were gated as live cells 
(Rl) and single cells (R2) were gated based on forward scatter. The R l 
and R 2 gates were used to collect the cellular fractions based o n B 2 2 0 
and C D 4 3 staining (as labeled- R 3 , R 4 , a n d R5). Post-sort analyses 
were performed to access the purity of the fractions. 
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(Figure 3.2.3a,b). All of these genes were expressed to varying levels 
during early B cell development. Expression of the analyzed target genes 
correlates with the expression of OCA-B, in that transcripts are 
minimally present in pro-B cells and show a substantial induction in 
pre-B cells (Figure 3.2.3 a and b). This indicates that OCA-B may serve 
to initiate a gene expression program that is important for pre-B cell 
development. 
Oca-b-/- Early B Cells Aberrantly Respond to Differentiation Signals 
Because OCA-B deficient mice showed a defect in early B cell 
development, we wished to look more closely at signaling pathways 
important for this transition and to determine if deregulation of OCA-B 
target genes could be contributing to the observed phenotype. A similar 
phenotype has also been described for the Slp-65' /- and Btk-/- mice, 
which also are hyper-responsive to IL-7 (Cheng et al., 1995; Turner et 
al., 1995; Jumaa et al., 1999; Middendorp et al., 2002; Flemming et al., 
2003). To examine the responsiveness of Oca-br/- cells to IL-7, total bone 
marrow B cells (CD19+) were isolated magnetically from Oca-b*/* and 
Oca-hr/-, mice and cultured for several days with IL-7. The cultures were 
sampled over a time course that extended to 168 hours of IL-7 exposure. 
In vivo, IL-7 is provided by stromal cells and serves to drive proliferation 
of interleukin receptor a (IL-7Ra) bearing B cells. Providing IL-7 to ex 
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Figure 3.2.3 Expression Pattern of O C A - B a n d its Target G e n e s in 
B o n e M a r r o w B Cells 
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A. Bone marrow B cells from Ocab*'* mice were collected by F A C S 
based o n surface expression of B220 a n d C D 4 3 , as s h o w n in Figure 
3.2.2. The populations collected were: B 2 2 0 / C D 4 3 - (non-B) B22CT 
/CD43+ (non-B), B220+/CD43+ (pro-B), B220med/CD43 (pre-B), and 
B220his»yCD43- (immature B). B. Expression of O C A - B target genes 
were examined by RT-PCR. Total bone marrow cells were prepared prior 
to sorting. G a p d h expression w a s used to normalize the samples. All 
of the reactions s h o w n are within the linear range of amplification for 
each target gene. C. Immunoblotting for O C A - B and its target gene 
products using whole cell extract from fractions s h o w n in A. 
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vivo cultured CD19+ cells stimulates differentiation of IL-7Ra bearing 
pro-B cells. In this culture system IL-7 responsive cells typically become 
larger in size, and this response was essentially normal in the knockout 
cultures (Figure 3.2.4b). In contrast, the Oca-b/-cells were found to be 
markedly hyperproliferative in the presence of IL-7, relative to its 
wildtype counterpart, as measured by counting live cells using flow 
cytometry (Figure 3.2.4a). A similar phenotype also was observed in 
long-term stromal cell-dependent Oca-b/- bone marrow cultures (data not 
shown). Since pre-BCR signaling is known to limit IL-7 responsiveness 
by promoting differentiation (Marshall et al., 1998), these results again 
indicate compromised pre-BCR signaling in Oca-b'/' cells and are 
consistent with the reduced responsiveness of these cells to BCR 
stimulation. Consistent with induction of the OCA-B protein level at the 
pre-B cell stage (Figure 3.2.3c), OCA-B was expressed throughout the IL-
7 time course (Figure 3.2.5). 
Defective Differentiation Capacity of Oca-br/- Pre-B Cells 
Given that the OCA-B deficient B cells showed an altered response to IL-
7 and that responsiveness to this signaling pathway is highly intertwined 
with signals emanating from the pre-BCR (Hendricks and Middendorp, 
2004), we further analyzed the developmental status of Oca-br/- cells 
throughout a time course of IL-7 exposure and subsequent removal. IL-
7 removal in this type of culture system serves to promote further 
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Figure 3.2.4 Altered R e s p o n s e of Oca-trf' B Cells to IL-7 
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A. C D 1 9 + cells were isolated from bone marrow of Oca-b*/* or Ocab/-
mice and cultured with media containing IL-7 for u p to 7 days. Live 
cells were counted using trypan blue exclusion to measure 
proliferation during the time course of IL-7 exposure (time points 
labeled). B. Analysis of cell size (FSC-H) during the IL-7 time course 
using FSC-H. 
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Figure 3.2.5 O C A - B Expression in IL-7 Cultured B Cells 
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W h o l e cell extracts from Oca-b*/* C D 19* cells cultured with IL-7 
were prepared at the indicated time points. After IL-7 removal, the 
culture w a s continued for 52h. O C A - B expression w a s monitored by 
immunoblot. 
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differentiation upon successful rearrangement of the immunoglobulin 
light chain (IgL), which is mediated by pre-BCR signaling (Rolink et al., 
1991). The prevalence of surface kappa+ cells following IL-7 removal can 
thus serve as an indicator of differentiation (Rolink et al., 1991; Ray et 
al., 1998). As expected, by 52 hours post-IL-7 removal, the wildtype 
culture had re-established a u7/k+ population (10%) (Figure 3.2.6a and 
Table 3.2.1). This differentiation step did not occur (within the given time 
period) in the rapidly proliferating Oca-b'/' culture such that, at 52 hours 
post-IL-7 removal, only 0.6% of live Oca-b'/' cells are li+/k+ (Figure 3.2.6a 
and Table 3.2.1). A failure to produce surface kappa positive cells upon 
removal of IL-7 from the Oca-b'/- cells further suggests a defect in pre-
BCR signaling, as opposed to an increased IL-7 sensitivity. It should be 
noted that both the wildtype and Oca-b/- cultures display a similar 
decrease in viability upon IL-7 removal, as assayed by flow cytometry 
using propidium iodide (data not shown). As expected, the existing 
li+/k+ cells that were present at the onset of the time course (T=0) died 
off at a similar rate due to lack of IL-7 responsiveness in both the 
wildtype and knockout cultures (T=0, T=48, T=145, Table 3.2.1). As 
previously reported (Hess et al., 2001), there were fewer IgM+/IgK+ cells at 
T=0 in Oca-b/- mice, which is due to a reduction of the re-circulating B 
cell pool. Additional analysis of cell surface marker expression over the 
time course showed that the Oca-b/- culture had an increased 
percentage of cells expressing the pre-BCR (SL-156) after 48 hours of IL-
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Figure 3.2.6 Defective Pre-BCR-mediated Differentiation o f 
Ocab"'' Cells 
A. Oai-b Oca-b 
38* i - 0 9 
) ii'". - I 
I.')'. - (1.3 
J P 7 
* - W 
M'. t (I 
I o', 10.6 / \ 
#<r-
T=145h 
T=-23h 
IL-7 
(i y, ± d,3 / 
4^ftV 
/ 
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(1.2'- ± 0.2 
r=-52h 
-n-7 
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-^y ^? 
c ^ / 
£ & m m 
y z $ y ,„ . 
A. C D 1 9 + cells were isolated from bone marrow by M A C S from 10 
Oca-b*'* or Oca-ir' mice a n d cultured with media containing IL-7 for 
u p to 142h. After IL-7 removal, the culture w a s continued for 52h. Ig 
k positive cells were monitored by flow cytometry. The increase in 
IgM+/IgK+ cells u p o n IL-7 removal in the Ocarb*'* culture indicates 
further differentiation. The percentages are average values from 
three experiments. 
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Figure 3.2.6- C o n t i n u e d 
B. 
Oca-b4 4Xh+IL-7 
U 
39! - h 8 
CD43 
Ckw-A 4Xh+IL-7 
52 691 - t 5 
B. Surface expression of the pre-BCR during the time course w a s 
analyzed by flow cytometry using the SL-156 antibody; and the 48-
hour time point is s h o w n . T h e values s h o w n are percentages of live 
cells within the pre-BCR+/CD43+ gate. The percentages are average 
values from three experiments. 
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7 exposure (31.2% vs. 52.4%) (Figure 3.2.6b). As expected, C D 4 3 and 
the pre-BCR were co-expressed on the cell surface, indicating the 
specificity of the SL-156 antibody (Figure 3.2.6b). A greater proportion 
of Oca-br/- cells remained CD43+ throughout the culture even after IL-7 
was removed (T=145, T=-22, Table 3.2.1). 
Deregulation of OCA-B Target Genes in Oca-br/- Mice Occurs Early in 
B Cell Development 
In order to further explain the impaired response of Oca-b/- cells, we 
wanted to determine if the expression levels of key genes involved in pre-
BCR signaling or other identified OCA-B target genes could be 
contributing to the effect. Pre-Bl cells (CD19+/CD43+/CD25-) and pre-
B2 cells (CD19+/CD43-/CD25+) were fractionated from wildtype or Oca-
b-/- mice by FACS (Figure 3.2.7). It should be noted that the markers 
used for fractionation of these two populations groups pro-B cells into 
the pre-B 1 cell fraction; however, the developmental block remains 
apparent when this fractionation scheme is applied (Figure 3.2.8a). 
Quantitative RT-PCR was then used to determine the expression levels of 
Vpre-B, A5, Igfi, Iga, ^constant, Lck, Cdc37, Btk, Lyn, Fyn, and Syk in the 
freshly isolated cells (Figure 3.2.8b,c and Table 3.2.2). As expected, up-
regulation of and A5 was observed in the pre-B 1 fraction relative to the 
pre-B2 fraction in both wildtype and Oca-br/- mice (Figure 3.2.8b). There 
was also a substantial (20-fold) induction of Lck gene expression in the 
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Figure 3.2.7 F A C S to Isolate Pre-B B Cells 
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80.6 
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Bone marrow B cells were collected by F A C S based on C D 1 9 - A P C , 
CD25-PE, and CD43-FITC surface marker expression. Pi-negative 
cells were gated as live cells. The live cells were then gated for size, 
followed by gating for F S C and S S C singlets. These gates were used 
to gate A P C + cells from which the cellular fractions were collected 
based on C D 2 5 , and C D 4 3 staining. 
Figure 3.2.8 Expression Levels of Critical G e n e s for Pre-B Cell 
Signaling in Oca-b'' M i c e 
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A. Early (pre-Bl) and late (pre-B2) pre-B cells were collected by F A C S 
based on expression of C D 19, C D 4 3 and C D 2 5 . B. and C. Quantitative 
R T - P C R was performed. The values s h o w n are fold changes calculated 
by relative quantification using Gapdh to compare R N A levels in pre-Bl 
versus pre-B2 cells for each genotype using the equations: ratio^E^^) 
ACT(Ctea-W+preBl-aca-b+/+prcB2)/(J£ \ACT(Oca-b+/+preBl-Oca-b+/+preB2) q- TatlO= 
/g \ACT(Oca-b-/-preB]-Oca-b-/-presB2)/fg \ACT(Qca-b-/-preBl-Oea-b-/-preB2> G e n e S 
that are induced in pre-Bl cells or pre-B2 cells are s h o w n in B. and C , 
respectively. All of the values s h o w n are averages (with standard 
deviations) generated from three to five independent experiments. 
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Table 3.2.2 Expression Levels of Genes Critical for Pre-B Cell 
Signaling 
Oca-b* ' VS. O c a-b Qess'm Oca-b i N=3-5 
G e n e 
\' , B 
a 5 
Lck 
[g (f. 
fgP 
R a g 2 
C d c 3 7 
u 
Btk 
Lyn 
Fyn 
Syk 
Total 
C D 1 9 + 
1.5 + 0.6 
1.5 ± 0 . 8 
( 1.7 ± 0 . 3 ) 
1.0 ± 0 . 2 
(8.0 ± 3 . 8 ) 
21 ± 7 . 8 
2.1 ± 1.2 
1.1 ± 0 . 4 
(1.5 ± 0 . 7 ) 
1.9 ± 0 . 8 
1.1 ± 0 . 4 
(2.1 ± 0 . 4 ) 
Pre-B I 
( + P 1 0 - B ) 
( 1.8 + 0 . 5 ) 
(2.8 ± 0 . 8 ) 
(5.6 ± 1.7) 
nd 
(5.0 ± 1.9) 
(5.2 + 2.3) 
( 1.3 + 0.1) 
1.2 ± 0 . 3 
2.2 ± 1.8 
1.6 ± 0 . 9 
nd 
2.3 ± 0 . 6 
Pre-B 2 
3.6 ± 1.4 
4.1 ± 0 . 4 
1.9 ± 0 . 7 
1 .6 ± 0.6 
( 1 .4 + 1 .0) 
3 . 2 + 1.4 
1.9 + 0.7 
(3.8 ± 3 . 6 ) 
1.3 ± 0 . 4 
1.0 ± 0 . 3 
2.3 ± 1.4 
1 .5 ± 0 . 5 
Quantitative R T - P C R w a s performed as in Figure 3.2.8. A similar 
m e t h o d w a s used to determine the difference in expression of genes 
between Oca-b*/* and Oca-b/' cells using the equation: ratio=(Etar^)A 
CT(Oca-b+/+prcBl-Oca-b-/-prcBl) /(}p \ACT(Oca-b+/+prcB 1 -Oca-b-/-prcBl) jTq_ gopfj Cell 
stage. A negative value denotes that Oca-b/- cells have fewer 
transcripts relative to wildtype cells. All of the values s h o w n are 
averages (with standard deviations) generated from three to five 
independent experiments. 
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pre-Bl fraction, which was not apparent in Oca-b'/' cells (Figure 3.2.8b). 
Conversely, several of the analyzed genes were expressed more highly in 
the pre-B2 fraction. These included Iga (7-fold), Igfi (7-fold), and Cdc37 
(11-fold) (Figure 3.2.8c). OCA-B was expressed at a relatively similar 
level in the wildtype pre-Bl and pre-B2 fractions (Figure 3.2.8c). It is 
difficult to compare levels of induction between the pre-Bl and pre-B2 
fractions of wildtype and Oca-b'/- mice because there may be differences 
in gene regulation at each stage of B cell development. In order to avoid 
this issue, we compared the relative expression (normalized to GAPDH) of 
these genes at each stage of development for wildtype versus Oca-br/-
mice (Table 3.2.2). Using this method of analysis, the Oca-b/- pre-Bl 
fraction showed significantly reduced expression (shown by parentheses) 
of two genes, Ig/3 and Lck that are involved in B cell signaling 
mechanisms (Table 3.2.2). Two of the genes analyzed, Vpre-B and A5, 
were also over-expressed in Oca-b/- pre-B2 cells (Table 3.2.2). The RNA 
levels of other kinases involved in B cell signaling, such as, BTK, LYN, 
FYN, and SYK, were relatively unaffected by the OCA-B deficiency (Table 
3.2.2). Expression of Cdc37, a newly identified OCA-B target gene in 
peripheral B cells (Kim et al., 2003), was not affected at either stage of 
pre-B ceU development (Table 3.2.2). 
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Analysis of Pre-BCR Signaling in Oca-br/ Cells 
Although we did observe alterations of gene expression in Oca-b/- mice, it 
remained possible that Oca-b'/- mice could be defective in cell signaling 
mechanisms; therefore, we directly analyzed pre-BCR function in Oca-br/-
cells. To study pre-BCR signaling capacity, the receptor was cross-linked 
using anti-u, after 48 hours of IL-7 stimulation, which allowed for the 
accumulation of pre-BCR+ cells (30-50% CD19+/CD43+/SL-156+) (Figure 
3.2.6b and Figure 3.2.9). To avoid cross-linking the mature BCR (up to 
20% of wildtype cells) (Figure 3.2.9), kappa+ cells were depleted prior to 
stimulation with anti-|j,. Flow cytometry analysis of the depleted 
population confirmed a near absence of mature cells after depletion (98% 
purity) (Figure 3.2.9b). As expected, pre-BCR signaling, as measured by 
global tyrosine phosphorylation, peaked at 5 minutes in the wildtype 
samples (Figure 3.2.9c). The Oca-br/- samples showed reduced tyrosine 
phosphorylation in response to pre-BCR cross-linking. Additionally, a 
reduction in phosphorylation was observed in the knockout culture at 
time 0 (Figure 3.2.9c). These data indicate that OCA-B may function 
more directly in B cell signaling pathways; however, given that LCK is an 
OCA-B target gene (Chapter 2 and Kim et al., 2003), it is possible that 
reduced LCK expression could also contribute to the early B cell defect of 
Oca-b/- cells. In order to examine this possibility we generated an LCK 
retroviral expression vector (Figure 3.2.10a) and infected CD19+ bone 
marrow B cells with LCK-expressing virus; however, expression of LCK 
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Figure 3.2.9 Analysis of P r e - B C R F u n c t i o n in Oca-b'- Cells 
A. Procedure to Analyze P r e - B C R Signaling 
Isolate C D 19+ B M cells- M A C S 
i 
Culture with IL-7- 48 hours (30-50% pre-BCR*) 
i 
Deplete Mature B cells (8-10%),IgK+ 
Culture without IL-7- 4 hours 
I 
Crosslink pre-BCR using anti-u. 
I 
Analyze Tyrosine Phosphorylation 
B. IgK-depleted Fraction 
Rl Gated 
FSC-H 
File: Kappa L>epleted-\VT 2 
Gate %Gated %Total 
Gl=Live 
G 2 = k * 
Iihi.imi 83.32 
2.65 % 21 
A. Procedure to analyze pre-BCR signaling. B. After depletion of 
kappa+ cells, anti-IgM FJab'^ fragment w a s used to crosslink the pre-
B C R for various lengths of time. 
Figure 3.2.9- Continued 
C. Global Tyrosine Phosphorylation 
Oca-b* Oca-b' 
0 5' 0 5' Anti-u 
pTYR 
Iga/Igp 
ACTIN 
C. Tyrosine phosphorylation in the cellular extract w a s monitored 
using anti-phosphotyrosine (pTYR). The bands corresponding to 
relevant phospho-proteins are labeled. The blot w a s normalized 
using ACTIN. The data is a representative of four experiments. 
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Figure 3.2.10 Analysis of Oca-b' Cell Proliferation After Infection 
with L C K - M I G R 1 
A. L C K - M G R 1 Expression 
( W C E from packaging cells) B. 
Batch 1 2 fc3 
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A. Expression of L C K protein from the retroviral construct w a s 
confirmed by immunoblot. B and C. C D 19+ cells from W T or Ocorb' 
(KO) mice were isolated as previously described. The cells were 
infected with L C K - G F P - M I G R 1 (LCK) or empty-GFP (MIGR1) virus and 
cultured as previously described. Proliferation of large cells (panel B) 
or G F P + cells (panel C) was monitored by flow cytometry. 
was unable to prevent the hyperproliferation of Oca-br/- cells in response 
to IL-7 (Figure 3.2.10b,c). These data indicates that OCA-B may play a 
role in early B cell signaling by regulating the expression of more relevant 
proteins such as BTK, SLP-65, and/or SYK. 
3.3 DISCUSSION 
The Role of OCA-B in the Pre-Bl to Pre-B2 Cell Transition 
The finding that a substantial fraction of cellular OCA-B is localized to 
the cytoplasm and membrane (Yu et al., 2001) strongly suggests that 
OCA-B has multiple roles in the cell and can function in processes other 
than transcription. The identification of a novel interaction between 
OCA-B and SYK supports this notion and has the potential to explain 
many aspects of the Oca-b/- phenotype— including the defects in early B 
cell development that are presented in this study. Early B cell 
development is marked by characteristic changes in cellular phenotype, 
that are regulated by a series of antigen-independent checkpoints 
mediated by cell signaling pathways and dependent on the successful 
rearrangement of the Ig locus (Hardy, 2003). Expression and signaling 
from the pre-BCR mediates the progression of developing B cells, first 
into large (cycling) pre-B 1 cells and then into small pre-B2 cells in which 
light chain rearrangement occurs. 
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The pre-Bl to pre-B2 transition is marked not only by a change in cell 
size but can be defined by changes in the display of cell surface markers 
such as CD43, CD117, CD2, pre-BCR, and CD25 (IL-2R) (Hardy and 
Hayakawa, 2001). By comparing the display of cell surface markers on 
wildtype and Oca-br/- bone marrow B cells, we have found that knockout 
mice have a significantly increased proportion of large B220+ cells. 
Likewise, these mice have an increased B220+CD43+CD25" compartment 
(mostly large cells) and, reciprocally, a decreased B220+CD43CD25+ 
compartment. This change represents a partial block in the pre-Bl to 
pre-B2 stage of B cell development in Oca-b/-mice. This defect is similar 
to that observed in mice deficient in Btk, Slp-65, or interferon regulatory 
transcription factors Irf4 and Irf8 (Khan et al., 1995; Jumaa et al., 1999; 
Pappu et al., 1999; Hayashi et al., 2000; Xu et al., 2000; Middendorp et 
al., 2002; Lu et al., 2003; Flemming et al., 2003). More importantly, this 
type of block, although more severe, has also been described in Sykr/-
mice (Cheng et al., 1995; Turner et al., 1995; Saijo et al., 2003). 
O C A - B a n d IL-7 Responsiveness 
OCA-B is known to play a role in BCR signaling, as evidenced by studies 
showing that Oca-b/- cells have reduced responsiveness to this signaling 
pathway (Kim et al., 1996). Additionally, many of the OCA-B target 
genes (such as Lck, Cyclin D3, Cdc37, and Kcnn4) that are induced by 
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B C R stimulation have n o w been shown to be expressed in pre-B cells. 
With this in mind, it seemed likely that the newly identified 
developmental block could be related to pre-BCR signaling. To examine 
this issue we utilized ex vivo cultured cells in the presence of IL-7. In 
mice, IL-7-mediated signaling promotes cellular proliferation and survival 
of IL-7Ra bearing B cells (Carsetti et al., 2000). It should be mentioned 
that mice with a targeted deletion of this gene have arrested B cell 
development at pro-B cell stage (impaired VDJ rearrangement), which 
occurs much earlier than the block described in this study, excluding the 
possibility that Oca-b/- mice are defective in IL-7R signaling, per se. 
Highly relevant to this study, it is suspected that pre-BCR signaling 
eventually leads to the termination of IL-7-induced proliferation via an 
SLP-65-BTK-dependent pathway (Marshall et al., 1998; Flemming and 
Paige, 2002, Hendriks and Middendorp, 2004). 
As reported for Btk-/- and Slp-65/- cells in the IL-7 culture system 
(Middendorp et al., 2002; Flemming et al., 2003), we have found Oca-b/-
cells to be markedly hyper-proliferative in the presence of IL-7. 
Additionally, we have shown that there is a substantial increase and 
persistence of pre-BCR+ cells within the Oca-br/- culture. This finding not 
only mimics the phenotype observed in vivo, but also further suggests 
that there is a build up of these cells due to inefficient mediation of IL-
7Ra signaling by the pre-BCR in the deficient cells. As mentioned 
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previously, another major outcome of pre-BCR signaling is to promote Ig 
light chain rearrangement, which, if successful, is followed by display of 
the mature BCR on the cell surface; and SYK exerts a major function in 
this signaling process. In the IL-7-driven culture system, this process 
occurs in wildtype cells following IL-7 removal, at which point IgK+ cells 
can be observed. Not only does this process fail to occur in the Oca-brl-
cells, but these cells also maintain a surface phenotype characteristic of 
pre-B cells. 
Contribution of Changes in Gene Expression to the Oca-br/- Early B 
Cell Block 
There are two possibilities that could explain the incomplete block of 
OCA-B deficient cells at the pre-Bl cell stage. The first, and less likely, 
situation is that these cells are simply delayed and can eventually correct 
themselves for transition into the pre-B2 compartment but at less than 
100% efficiency. The second possibility, which is more common in the 
case of deficiencies affecting lymphopoeisis, is that some cells can 
progress developmentally despite their altered state. One way to address 
this issue was to analyze gene expression patterns in pre-Bl and pre-B2 
cells of wildtype versus Oca-b/- mice. In the first scenario, one would 
expect to observe gene expression changes only in the pre-Bl fraction. 
However, significant alterations in gene expression also were observed in 
Oca-b/- pre-B2 cells, indicating that they cannot efficiently turn off 
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surrogate light chain (SLC) expression despite having cell surface 
markers characteristic of pre-B2 cells. Downregulation of SLC is an 
outcome of pre-BCR signaling and is coincident with termination of 
proliferation in response to IL-7 (Hendriks and Middendorp, 2004). 
As mentioned previously, an increase in pre-BCR+ cells was shown in the 
Oca-b'/- IL-7 culture, which could be due to their enhanced proliferative 
capacity or to an enhanced expression of pre-BCR components. We have 
shown that the latter possibility is unlikely because we did not find 
increased expression of the pre-BCR light chains (Vpre-B and X.5) in Oca-br 
/- pre-Bl cells. Nor was there increased expression of u-constant in the 
knockout cells, which is expected since OCA-B is a coactivator of 
immunoglobulin gene transcription. A pronounced decrease was 
observed in the reported (Mallone and Wall, 2002) OCA-B target gene Igp\ 
While the LCK RNA level was reduced in Oca-b/- cells, importantly, other 
kinases involved in pre-BCR signaling such as, BTK, SYK, FYN, and LYN 
are largely unaffected at the RNA level by OCA-B deficiency in both pre-
Bl and pre-B2 cells; however, it remains possible that OCA-B functions 
to regulate unidentified target genes involved in pre-BCR signaling. The 
mechanism underlying the defective pre-B cell transition and signaling in 
Oca-br/- mice will be explored further in the next chapter. 
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C H A P T E R 4 
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R e q u i r e d f o r S i g n a l i n g a t M u l t i p l e S t a g e s 
o f B C e l l D e v e l o p m e n t 
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4.1 P R E F A C E : T H E M E C H A N I S M B Y W H I C H O C A - B F U N C T I O N S IN 
PRE-BCR AND BCR SIGNALING? 
As shown in the previous chapter, analysis of early B cell surface marker 
expression and proliferative capacity of Oca-b/ bone marrow B cells have 
revealed defects in the pre-Bl to pre-B2 cell transition, in pre-BCR 
signaling, and in IL-7 responsiveness. Expression studies of the recently 
identified OCA-B target genes, as well as, genes involved in pre-BCR 
signaling, have also been performed in order to access possible 
contributions to the observed phenotype. This analysis has revealed a 
reduction of the LCK and IgP RNA levels in early B cells from Oca-b'/-
mice. A reduction of the LCK RNA level was also observed in various 
mature B cell subsets. While the study presented in the previous 
chapter led to the characterization of LCK expression and transcriptional 
regulation by OCA-B, we suspected that OCA-B might function in pre-
BCR/BCR signaling through additional mechanisms. Although LCK 
might be involved in B cell development, it is thought to be of marginal 
importance for BCR signaling in mature splenic B cells. Furthermore, the 
finding that a substantial fraction of cellular OCA-B is localized to the 
cytoplasm and membrane (Yu et al., 2001) strongly suggests that OCA-B 
has multiple roles in the cell and can function in processes other than 
transcription. 
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4.2 R E S U L T S 
Further Analysis of Pre-BCR Signaling in Oca-br/- Cells 
As discussed in the previous chapter, because we had observed that Oca-
b'/' pre-B cells are hyperproliferative in response to IL-7 and have 
reduced expression of a pre-BCR signaling component (Ig(3), we then 
analyzed pre-BCR function in these cells. The Oca-br/- samples showed 
reduced tyrosine phosphorylation in response to pre-BCR cross-linking 
(Figure 3.2.9). In order to further examine this defect, we performed 
additional pre-BCR crosslinking studies using a time course of 
stimulation (Figure 4.2.1a). As expected, pre-BCR signaling peaked at 2 
minutes in the wildtype samples (Figure 4.2.1a, upper panel). As before, 
a lower initial phosphorylation was observed in the knockout culture 
(Figure 4.2.1a, upper panel). This interesting finding led us to examine 
the total protein levels of relevant kinases, and this analysis revealed 
that SYK expression is severely reduced in Oca-b'/ pre-B cells even in the 
absence of pre-BCR activation (Figure 4.2.1a, lower panel). The 
expression of LCK, the product of an OCA-B target gene, also was 
reduced, albeit less dramatically, while FYN and ERK expression levels 
were unaffected (Figure 4.2.1a, lower panel). Since the SYK protein level 
is heavily regulated by ubiquitin-mediated proteolysis (Duan et al., 
2004), we wanted to determine if the SYK RNA level is also affected in the 
IL-7 cultured cells. Cultured CD19+ cells were sampled over a 96-hour 
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Figure 4.2.1 Analysis of Pre-BCR Function a n d S Y K Expression in 
Oca-b' Cells 
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A. CD19+ cells were isolated from 
bone marrow of 12 mice and cultured 
in IL-7 for 48h. After depletion of 
kappa' cells, anti-IgM F(ab*)2 
fragment was used to crosslink the 
pre-BCR for various lengths of time. 
Tyrosine phosphorylation in the 
cellular extract was monitored using 
anti-phospho tyrosine (pTYR). The 
band corresponding to S Y K is 
labeled. The total protein levels of 
SYK, LCK, E R K , FYN, and O C A - B were also examined. The blot w a s 
normalized using ACTIN. The data is a representative set from four 
experiments. B. Q P C R was used to analyze S Y K R N A levels in the cells 
that were used for the experiment in panel A. Relative quantification 
was used to compare the genotypes, a negative value denotes less in 
transcript in Oca-b/ cells. The values shown are averages generated 
from three of the experiments performed for panel A. 
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time course of exposure to IL-7. Quantitative P C R was then used to 
compare the amount of SYK mRNA in Oca-br/- versus wildtype IL-7-
cultured pre-B cell samples (normalized using GAPDH). Interestingly, the 
SYK RNA level was reduced only marginally (2.9 fold), relative to the SYK 
protein level, after 48 hours of culture (Figure 4.2.1b). This coincides 
with the moderate reduction (2.6-fold) observed in freshly isolated pre-B 
cells (Table 3.2.2). Importantly, significant reductions in the SYK and 
LCK proteins levels were also observed in freshly isolated Oca-b/- early B 
cells (Figure 4.2.2a,b), which indicates that the reduction of SYK in Oca-
b-/- cells is not a by-product of the IL-7 culture system. 
Regulation of SYK Expression in Oca-b/- Cells 
Since the SYK protein level was dramatically reduced in Oca-b/- cultured 
pre-B cells and since it is difficult to directly compare quantitative PCR 
values with immunoblot data, we wished to determine if Syk is a direct 
OCA-B target gene. Two non-consensus octamer sites were identified in 
the predicted Syk promoter region. However, occupancy of these sites by 
OCT or OCA-B was not observed in IL-7 cultured primary cells or in the 
murine lymphoblastic A20 cell line by chromatin immunoprecipitation 
assays (not shown). Given that the chromatin immunoprecipitation 
assays were negative and that QPCR showed no difference in SYK RNA 
levels in vivo (Table 3.2.2) and only marginally during the IL-7 culture, 
we conclude that SYK is not a transcriptional target of OCA-B. 
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Figure 4.2.2 Analysis of S Y K Protein Levels in Sorted B o n e 
M a r r o w B Cells 
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A. Early (pre-Bl) and late (pre-B2) pre-B cells were collected from 10 
mice/genotype by FACS based on expression of C D 19, CD43, and 
CD25. B. Immunoblotting was performed for SYK, LCK, ACTIN and 
ERK. The data is representative of two experiments. 
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Importantly, S Y K is heavily regulated at the level of protein stability via 
proteosome-dependent pathways in many hematopoetic cell types 
(Yankee et al., 1999; Paolini et al., 2001; Paolini et al., 2002; Sohn et al., 
2003). To explore the possibility that OCA-B may affect only SYK protein 
levels through its degradation pathway, we first examined SYK 
expression in peripheral B cells from wildtype and Oca-b/- mice (Figure 
4.2.3a-c). Splenic B cells were isolated and cultured for up to 120 hours 
with anti-IgM (BCR stimulation), anti-IgM, anti-CD40, and IL-4 (co-
stimulation to mimic T cell-dependent signaling) or with LPS. Analysis of 
the SYK expression patterns by immunoblot revealed marked reductions 
in the SYK protein level for all of the activation conditions tested (Figure 
4.2.3a-c). However, a less pronounced reduction of SYK expression in 
Oca-b-/- cells was observed when the cells were cultured in the presence 
of LPS as compared to what was observed for cells cultured in the 
presence of anti-IgM or anti-IgM, anti-CD40, and IL-4. Importantly, SYK 
is dynamically regulated in the wildtype cells activated with anti-IgM, 
anti-CD40, and IL-4, which is consistent with this type of stimulation 
promoting both proliferation and differentiation, as opposed to 
proliferation alone during activation with anti-IgM or LPS. In contrast, 
the protein levels of other kinases such as LYN, FYN and ERK were not 
affected by the OCA-B deficiency (Figure 4.2.3a-c and data not shown). 
There was a significant increase of SYK that is tyrosine phosphorylated 
in the linker region at residue 317 in the knockout cells (Figure 4.2.3a). 
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Figure 4.2.3 Analysis of S Y K Protein Levels in Mature B Cells 
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Total B cells were isolated from the spleens of 10 Oca-b*'* or Oco-bA 
mice. The cells were activated in culture with anti-IgM F{ab')2 
fragment (A), anti-IgM F(ab*)2 fragment, anti-CD40, and IL-4 (B), or 
LPS (C) for up to 120 hours. Expression of SYK, phosphorylated S Y K 
at tyrosine 317 (SYKpY317) and E R K were analyzed by immunoblot. 
The activation experiments were performed three times for this 
study. 
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S Y K is phosphorylated at this residue by LYN, which then allows S Y K to 
be targeted for ubiquitin-mediated degradation by CBL (Keshvara et al., 
1998; Lupher et al., 1998; Ota and Samelson, 1999; Yankee et al., 1999; 
Rao et al., 2001; Hong et al., 2002). The increased phosphorylation at 
this site in mature B cells from Oca-b/- mice indicates that SYK is less 
stable in the absence of OCA-B. In order to confirm that the observed 
reduction of the SYK protein level in Oca-b/- mature B cells is a direct 
result of reduced SYK protein stability, we analyzed SYK degradation in 
the presence of cycloheximide (Figure 4.2.4). Mature resting B cells were 
isolated and cultured with anti-IgM and cycloheximide. Analysis of SYK 
protein levels by immunoblot indicated that SYK is highly unstable in the 
Oca-b'/' cells relative to the wildtype cells (Figure 4.2.4). 
Since the SYK protein level was affected at multiple stages of B cell 
development (early and peripheral B cells) and since Syk is not a 
transcriptional target of OCA-B, we wanted to further explore the 
mechanism by which OCA-B regulates SYK stability. OCA-B is present 
in the cell as two isoforms, arising from different translation start sites 
(Yu et al., 2001). The larger form, p35, is myristoylated and is localized 
predominantly to the cytoplasm and plasma membrane (Yu et al., 2001); 
therefore, it is plausible that OCA-B and SYK could interact in the 
cytoplasm or at the membrane. To investigate this possibility, we 
performed immunofluorescence microscopy to determine if OCA-B and 
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Figure 4.2.4 S Y K Stability in Oca-br'- Splenic B Cells 
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Resting B cells were isolated from spleens of Oca-b*/* or Oca-b'' 
mice a n d activated with anti-IgM F(ab')2 fragment for u p to 2 4 hours 
either in the presence (+CHX, panel B) or absence (-CHX, panel A) 
of cycloheximide. The stability of S Y K and E R K were monitored by 
immunoblot. 
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S Y K colocalize. Namalwa cells, a h u m a n Burkitt's lymphoma B cell line, 
were used for these experiments. The localization of IgM, SYK, and OCA-
B was analyzed over a time course of BCR (anti-IgM) stimulation or co-
stimulation (anti-IgM, anti-CD40, and IL-4) (T=0, 10', 40', 120'). Analysis 
of IgM fluorescence showed a characteristic aggregation of the BCR with 
stimulation by anti-IgM (Figure 4.2.5). Colocalization of OCA-B and IgM 
was frequently observed upon BCR stimulation, as shown by 
representative data in Figure 4.2.5. As expected, SYK and IgM also 
colocalized to the membrane (Figure 4.2.5 and 4.2.6). Interestingly, the 
pattern of OCA-B distribution was altered both with BCR stimulation 
and with co-stimulation such that a significant number of cells 
(p=0.0057) showed a strong cytoplasmic localization of OCA-B by the end 
of the anti-IgM stimulation time course (Figure 4.2.5, 4.2.6, and 
4.2.7blue). The significant increase of cells with OCA-B in this 
configuration during co-stimulation was more rapid, occurring within 10 
minutes (p=0.004) (Figure 4.2.7b, red), which suggests that the 
redistribution of OCA-B is signal-dependant. Furthermore, colocalization 
of SYK and OCA-B could be observed in cells that had strong cytoplasmic 
staining of OCA-B (Figure 4.2.5 and 4.2.6). Similar results were also 
obtained by imaging Daudi cells, another Burkitt's lymphoma cell line 
(data not shown). Interestingly, some of the cells showed both nuclear 
and cytoplasmic staining for SYK (Figure 4.2.5). This correlates with 
Namalwa nuclear extracts having a significant amount SYK, as detected 
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Figure 4.2.5 I m m u n o f l u o r e s c e n c e M i c r o s c o p y to Analyze 
Localization of IgM, S Y K , a n d O C A - B u p o n B C R 
Stimulation 
IgM O C A - B Merge D a pi 
T=0 
1 M 2 0 
T=0 
1 M 2 0 
T=0 
T=120 
N a m a l w a cells were stimulated with anti-human IgM for 120 minutes 
(T=120) or left unstimulated (T=0). After fixation a n d permeabilization 
the localization of IgM (red-AlexaFluor546)) O C A - B (green-
AlexaFluor488), and S Y K (green-AlexaFluor488) w a s analyzed. To s h o w 
co-localization the red and green channels were merged (merge). D A P I 
w a s used for nuclear staining. The data is representative of three 
experiments. 
Figure 4.2.6 I m m u n o f l u o r e s c e n c e M i c r o s c o p y to Analyze 
Localization of I g M , S Y K , a n d O C A - B u p o n Co-
Stimulation 
O C A - B Merge 
T = 0 
T = 1 0 
T*=0 
T>10 
T = 0 
T = 1 0 
N a m a l w a cells were stimulated with anti-human IgM, anti-human 
C D 4 0 and recombinant h u m a n IL-4 for u p to 120 minutes or left 
unstimulated (T=0), the 10 minute time point is s h o w n (T=10). The 
cells were stained a n d imaged as in panel A. The data is 
representative of three experiments. 
Figure 4.2.7 Statistical Analysis of O C A - B Localization Patterns 
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The occurrence of N a m a l w a cells with cytoplasmic staining of O C A - B 
(as visualized by immunofluorescence microscopy) during a time course 
of stimulation is presented. For each time point, 600 cells were scored 
for having either nuclear and cytoplasmic (A) or mainly cytoplasmic (B) 
staining for O C A - B . Counting w a s performed for three independent 
experiments in order to generate the averages and standard deviations 
shown. With anti-IgM stimulation (shown in blue), the decrease in 
cells having nuclear plus cytoplasmic staining between 0 and 120 
minutes has a significance of p=0.0131 (left panel) and the increase in 
cells having cytoplasmic staining has a significance of p=0.0057 (right 
panel). During co-stimulation (shown in red), the decrease in cells 
having nuclear plus cytoplasmic staining between 0 a n d 10 minutes 
has a significance of p^O.OOS and the increase in cells having 
cytoplasmic staining has a significance of p=0.004. 
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by immunoblot (data not shown). 
Characterization of the OCA-B-SYK Interaction 
To confirm that the observed colocalization represents a protein-protein 
interaction between OCA-B and SYK, we performed immunoprecipitation 
experiments. BCR crosslinking with anti-IgM was performed for various 
lengths of time (0, 3', 10', 30', 2 hours, 5 hours) on wildtype splenocytes. 
Whole cell extracts from these cells were used for immunoprecipitation 
with anti-OCA-B. SYK was immunoprecipitated with OCA-B at T=0 and 
showed an increased level of co-immunoprecipitation for up to 10 
minutes of BCR crosslinking (Figure 4.2.8a). The increased association 
of OCA-B and SYK was coincident with increased tyrosine 
phosphorylation (detected by immunoblot with anti-pTYR) (Figure 
4.2.8a). By 2 hours the amount of SYK associated with OCA-B was 
roughly back to that of the resting state (T=0) (Figure 4.2.8a). 
Because SYK expression was reduced in Oca-br/- mature B cells that have 
been activated in culture with anti-IgM, anti-CD40 and IL-4 for long 
periods of time, we wanted to analyze the interaction between OCA-B and 
SYK in this context. For this, splenocytes were co-stimulated with anti-
IgM, anti-CD40, and IL-4; and an immunoblot analysis of the derived 
extracts revealed that the interaction decreased with time (Figure 4.2.8b). 
By 40 hours the association of SYK and OCA-B was marginal compared 
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Figure 4.2.8 Identification of the O C A - B - S Y K Interaction 
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A. Ocarb*/* splenic B cells were activated in culture with anti-IgM 
F(ab')2 fragment for a time course from T = 0 to 5 hours. 
Immunoprecipitation (IP) w a s performed using anti-OCA-B or IgG 
(control) and whole cell extract. The presence of S Y K in the IP w a s 
monitored by immunoblotting. The total level of S Y K , E R K and 
tyrosine phosphorylated proteins (pTYR) in the whole cell extract 
( W C E ) w a s also examined. B. Ocarb*/* splenic B cells were activated in 
culture with anti-IgM F(ab*)2 fragment, anti-CD40, and IL-4. 
Immunoprecipitation of O C A - B or S Y K w a s detected by immunoblot. 
The total protein level from whole cell extract ( W C E ) is also s h o w n for 
O C A - B and E R K (bottom panels). All of the immunoprecipitation 
experiments were reproduced at least four times each. 
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to T=0 and by 65 hours S Y K protein was no longer present (Figure 
4.2.8b). The dramatic induction of OCA-B expected at later time points 
of co-stimulation (Kim et al., 2003) also was observed. Interestingly, a 
lasting interaction between OCA-B and SYK could not be detected in 
wildtype splenic B cells that have been stimulated with LPS, which is 
consistent with the finding that SYK levels are not as dramatically 
affected in LPS-stimulated Oca-b/- cells (Figure 4.2.9 and 4.2.3c). SYK 
was also coimmunoprecipitated with OCA-B in total bone marrow B cells, 
indicating that the SYK-OCA-B interaction also occurs in early B cells 
(Figure 4.2.9b). 
In order to determine if the interaction between SYK and OCA-B is direct, 
we performed GST-pulldown experiments using bacterially expressed 
GST-OCA-B fusion proteins and bacterially expressed histidine-tagged 
full length SYK. GST-fusion proteins containing full-length (residues 1-
256), N-terminal (residues 1-154), and C-terminal (residues 154-256) 
OCA-B were purified and normalized for the pulldown according to the 
amount of full-length product (Figure 4.2.10a). The GST-pulldown 
showed a direct interaction between SYK and OCA-B, with SYK having 
the highest affinity for the C-terminus of OCA-B (Figure 4.2.10b). 
Since we observed colocalization of OCA-B and SYK in the cytoplasm 
(Figure 4.2.5), it was necessary to determine if SYK preferentially 
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Figure 4.2.9 Characterization of the OCA-B-SYK Interaction 
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A. Ocarb*'* splenic B cells were activated in culture with LPS for a 
time course from T=0 to 89 hours. Immunoprecipitation (IP) was 
performed using anti-OCA-B or IgQ (control) and whole cell extract. 
The presence of SYK in the IP was monitored by immunoblotting. The 
total level of SYK, OCA-B, and E R K in the whole cell extract (WCE) 
was also examined (bottom panels). B. CD19+ bone marrow B cells 
from Ocab*'* mice were purified by M A C S and whole cell extract was 
prepared. Immunoprecipitation of SYK was detected by immunoblot. 
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Figure 4.2.10 Characterization of the OCA-B D o m a i n Required for 
Interaction with S Y K 
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A. Coomassie blue-stained SDS-gel showing purified G S T or G S T - O C A -
B proteins (products m a k e d by arrows). B. Purified His-tagged S Y K 
w a s incubated with immobilized G S T or G S T - O C A - B proteins and 
bound S Y K w a s monitored by immunoblotting. This experiment w a s 
performed at least three times using u p to 500 m M K C L . 
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associates with OCA-B p35, the myristoylated form. W e performed Ni-
NTA pull down assays using bacterially expressed histidine-tagged full 
length SYK and either whole cell (WCE), cytoplasmic (S100), or nuclear 
(NE) extracts from Namalwa cells. Histidine-tagged full-length SYK was 
able to pull down both forms of OCA-B with relatively equal efficiencies 
(Figure 4.2.11a; see figure legend). This data is consistent with a strong 
OCA-B interaction with SYK through its C-terminus, which is the same 
for both forms of OCA-B. Because we have observed reduced nuclear 
staining in Namalwa cells for OCA-B upon stimulation with anti-IgM 
(Figure 4.2.7a), we wanted to analyze the interaction between OCA-B and 
SYK in this context. We performed immunoprecipitation experiments 
with anti-OCA-B and whole cell extract from Namalwa cells that had 
been stimulated with anti-IgM over a time course. This analysis revealed 
an increased OCA-B-SYK association that correlated with the increase in 
the cytoplasmic localization of OCA-B (Figure 4.2.11b). Interestingly, 
immunoblotting for phosphotyrosine revealed that phosphorylated SYK 
does not co-immunoprecipitate with OCA-B (Figure 4.2.11b- pTYR, lower 
panel). 
To examine the interaction between OCA-B and SYK in more detail, we 
mapped the SYK domain that interacts with OCA-B. Histidine-tagged-
SYK proteins were generated in a manner consistent with the domains of 
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Figure 4.2.11 Analysis of S Y K Interaction with p34- Versus 
p35-OCA-B and Examination of S Y K Phosphorylation 
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A. Purified His-tagged SYK or Ni-NTA beads alone (control) were 
incubated with Namalwa cellular extracts. The binding of OCA-B was 
monitored by immunoblotting. Long and short exposures are shown to 
distinguish OCA-B p34 and p35. This experiment was reproduced five 
times. B. Whole cell extracts from Namalwa cells that were stimulated 
with anti-IgM for a time course were used for immunoprecipitation with 
anti-OCA-B. The presence of SYK was analyzed by immunoblot. Th€ 
presence of tyrosine phosphorylated proteins (pTYR) was monitored in 
the W C E and IP by immunoblot. The band that corresponds to S Y K is 
labeled. This experiment was performed twice. 
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S Y K (Figure 4.2.12a). Other than full-length SYK, only S Y K fragments 
containing the kinase domain are able to efficiently pull-down both forms 
of OCA-B from cytoplasmic extracts (S100) (Figure 4.2.11a and 4.2.12b). 
Of the kinase domain-containing SYK fragments, those containing the C-
terminal portion of the kinase domain are able to interact with OCA-B 
most efficiently (Figure 4.2.12b). 
Although both isoforms of OCA-B are able to interact with SYK in vitro 
(Figure 4.2.11 and 4.2.12), we wanted to determine if this occurs in vivo. 
To this end, BAC-transgenic mice that specifically lack expression either 
of OCA-B/p35 or expression of OCA-B/p34 in B cells were generated on 
the Oca-hr/- background. In this way, loss of function of one form can be 
assessed using BAC clones in which the OCA-B locus has been 
genetically modified by introducing point mutations in one of the two 
translation start sites. We have confirmed that the transgenic mice 
obtained have the expected pattern and selectivity of OCA-B expression 
(data not shown). CD19+ cells were harvested from the bone marrow of 
these mice and cultured in the presence of IL-7 (Figure 4.2.13). All of the 
transgenes {Oca-b*/*, p34+/+, p35+/+) were able to reverse the 
hyperproliferation defect of Oca-b/- mice (Figure 4.2.13s). Consistent 
with the in vitro interaction data, the OCA-B p34 and p35 transgene 
products were both able to stabilize SYK in Oca-br/- mice (Figure 4.2.13b). 
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Figure 4.2.13 Rescue of Oca-b' Mice with OCA-B-Expressing 
Transgenes 
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A. CD19+ B cells were isolated from bone marrow of Ocab*/* {Ocarb/ with 
wildtype Oca-b transgene), p34*/* [Ocab/ with p34-Ocarb transgene), 
p35*'* [Oca-b/ with p35-Oca-b transgene), or Ocarb/ (no transgene) mice 
and the experiment was carried out as in Figure 2A. B. Whole cell extract 
was prepared from CD19+ bone marrow B cells that had been cultured in 
IL-7 for 48 hours. The ability of S Y K protein stability to be restored in the 
transgenic mice was monitored by immunoblot. This experiment was 
performed twice. 
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In order to further develop the analysis w e used Syk conditional 
knockout (Syk-/-) mice that had been generated using Cre-mediated 
recombination (Saijo et al., 2003). As mentioned previously, Syk:/' mice 
also have a block in early B cell development (Cheng et al., 1995; Turner 
et al., 1995; Saijo et al., 2003). Total bone marrow B cells (CD19+) were 
isolated magnetically from Oca-b*/*, Oca-br/', Syk*/*, or Syk-/- mice and 
cultured for several days with IL-7. The cultures were sampled over a 
time course that extended to 168 hours of IL-7 exposure. Like the Oca-br 
/- cells, the Syk-/- cells were also hyperproliferative in the IL-7 culture 
(Figure 4.2.14a). By day 7 of the time course there was a substantial 
increase of Oca-b/- and Syk:/- cells relative to the wildtype cultures 
(Figure 4.2.14b). These data further indicate that the absence of SYK in 
Oca-b/- mice is responsible for creating the block in pre-B cell 
development caused by defective pre-BCR signaling. 
4.3 DISCUSSION 
The Role of OCA-B in Pre-BCR Signaling 
We have shown that pre-BCR signaling capacity is reduced in Oca-br/-
mice as a direct result of a severe defect in SYK expression. 
Mechanistically, this explains the developmental block observed in vivo 
as well as the hyperproliferation of Oca-br/- cells in response to IL-7. As 
121 
Figure 4.2.14 Characterization of Syrf' Cells in the IL-7 Culture 
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mentioned, S Y K expression appears to be less severely affected in freshly 
prepared (FACS) cells than in cells that have been cultured in IL-7. 
Nevertheless, both methods of analysis indicated the same pattern, thus 
strengthening the argument that the disruption of SYK protein levels 
plays a critical role in the development of the Oca-b'/' phenotype. 
OCA-B-SYK Interaction in Antigen-Dependent B Cell Differentiation 
A severe reduction in SYK protein levels was also observed in OCA-B 
deficient splenic B cells and can be directly attributed to reduced SYK 
stability in Oca-b''- cells. SYK protein was reduced more quickly and to 
a greater extent in knockout cells stimulated with anti-IgM or a 
combination of anti-IgM, anti-CD40 and IL-4. Oca-b'/- mice display a 
significant reduction in follicular B cells and also have a general 
reduction of peripheral B cells (Schubart et al., 1996, Kim et al., 2000). 
Interestingly, Syk-/- mice can develop immature B cells in the periphery, 
but they fail to enter follicles or the recirculating B cell pool (Turner et 
al., 1997). Therefore, it is possible that the reduced SYK stability and the 
resulting decrease in protein level in Oca-b'/' B cells contributes to the 
decrease in follicular and recirculating B cells in Oca-br/- mice. In the 
case of activation with anti-IgM, anti-CD40, and IL-4, which mimics T 
cell-dependent stimulation, wildtype cells showed a reduction in SYK by 
65 hours, a change that correlates with differentiation of these cells as 
evidenced in part by increased IgGl transcription (Kim et al., 2003). The 
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more dramatic reduction of S Y K protein levels in the knockout cells m a y 
contribute to the compromised antigen-dependent immune response of 
Oca-b'/- mice. 
Mechanism of OCA-B-SYK Interaction 
The mechanism by which OCA-B effects SYK protein levels is 
unexpected, since SYK is not a transcriptional target of OCA-B as judged 
by QPCR and chromatin immunoprecipitation assays. Because of this, 
alternative functions of OCA-B, both direct and indirect, need to be 
considered. The most obvious evidence to support a direct effect by 
OCA-B on SYK protein stability is that the two proteins strongly interact, 
as shown both in vitro by assays with bacterially expressed (unmodified) 
forms at high salt concentration and in vivo by co-immunoprecipitation. 
Also, SYK is heavily regulated at the protein level by ubiquitin-mediated 
degradation (Keshvara et al., 1998; Lupher et al., 1998; Ota and 
Samelson, 1999; Yankee et al., 1999; Rao et al., 2001; Hong et al., 2002) 
and, importantly, we have demonstrated that SYK stability is reduced in 
the Oca-b'/' IgM-cultured mature B cells. This regulation is mediated by 
CBL, a ring finger ubiquitin ligase that binds to SYK that has been 
tyrosine phosphorylated in its linker region (residue 317); 
phosphorylation at this site is critical for SYK degradation (Keshvara et 
al., 1998; Lupher et al., 1998; Yankee et al., 1999; Sada et al., 2000; 
Hong et al., 2002; Sohn et al., 2003). Significantly, this phosphorylated 
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form of S Y K was increased in Oca-b/- cells that had been stimulated with 
anti-IgM; however, OCA-B interacts with unposhorylated SYK. This 
increase in phosphorylated SYK and the decrease in total SYK levels due 
to SYk instability in the knockout cells may be a result of OCA-B being 
unavailable to interact with and stabilize SYK. This stabilization most 
likely effects the inactive form of SYK because OCA-B interacts with 
unphophorylated SYK through its kinase domain. This would be a 
unique and novel mechanism by which SYK protein levels are 
maintained. 
Another interesting aspect of the interaction between SYK and OCA-B is 
that the interaction increases with BCR signaling and can occur with 
either form of OCA-B (Figure 6A, E and F, Figure 7). Consistent with the 
C-terminus of OCA-B being most important for interaction with SYK, 
pull-down and immunoprecipitation assays showed that SYK can 
interact with both the myristoylated-p35 and p34 forms of OCA-B and 
rescue experiments in Oca-b/- mice showed that both forms of OCA-B are 
able to stabilize SYK in vivo and to rescue the IL-7 hyperproliferation 
defect. Additionally, immunofluoresence analyses showed co-
localization of OCA-B and SYK in Namalwa cells that had been 
stimulated with anti-IgM. The Namalwa cells showed responsiveness to 
BCR signaling, in that IgM became more aggregated with treatment. The 
significantly increased incidence of cells with "nuclear exclusion" of OCA-
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B following B C R stimulation could be related to its interaction with S Y K 
because increased association between OCA-B and SYK was detected by 
immunoprecipitation using extracts from these cells (Figure 5C and 6F). 
Possibly related to this idea, there was also a fraction of cells that had 
strong nuclear staining for SYK. Nuclear localization of SYK has been 
reported previously and is dependent on a nuclear localization signal in 
the linker region (Ma et al., 2001; Wang et al., 2003), although the 
functional significance of this finding has not been fully determined. 
Further investigation into the translocation of OCA-B within the cell 
could provide yet another example of the unique behavior of this 
transcriptional cofactor and could also reveal alternative functions for 
SYK. 
Dual Function of OCA-B in B Cell Signaling 
Although OCA-B is best known for its function as a transcription 
coactivator, this study has provided further evidence that OCA-B can 
function by multiple mechanisms within the cell (Figure 4.3.1). As a 
transcription factor, OCA-B activates a subset of genes that are 
important in cell signaling (Kim et al., 2003). Although there is also a 
severe reduction in LCK RNA and protein levels in Oca-b/- pre-B cells, 
Lck-/- mice display a normal pre-Bl to pre-B2 transition and grow 
normally in an IL-7 culture (data not shown). Therefore the reduction in 
LCK is not likely to be responsible for the defects in pre-B cell 
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differentiation in Oca-b/- mice. However, regulation of O C A - B target 
genes has been shown to be important for other aspects of B cell 
differentiation, in particular mature B cell function (Teitell, 2003). 
Interestingly, the OCA-B-SYK interaction occurs early during B cell 
activation when OCA-B expression is relatively low. When OCA-B 
expression is at the highest level, later in the activation program, not 
only is the OCA-B-SYK interaction no longer apparent but the 
transcriptional targets of OCA-B start to be induced (Figure 4.2.8b and 
4.2.9a and Kim et al. 2003). These findings indicate that OCA-B plays 
dual roles in the cell, making it broadly important for B cell signaling. It 
not only can regulate early events in intracellular signaling by direct 
interaction with signaling components (SYK), but it can also function 
classically as a transcription coactivator on downstream target genes at 
later stages of B cell activation. 
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Multi-Functional O C A - B 
OCA-B is a protein of many surprises. Historically, OCA-B was the first 
cell-type specific coactivator identified (Pierani et al., 1990; Luo et al., 
1992; Luo and Roeder et al., 1995). OCA-B was found to function 
specifically either with the ubiquitious transcription factor OCT-1 or with 
the related cell-type restricted transcription factor OCT-2 to mediate B 
cell restricted activation of target genes (reviewed in Luo and Roeder, 
1999). Although initially characterized for its function at Ig promoters, 
OCA-B was later found to function at the IgH 3' enhancer (Tang and 
Sharp, 1999; Stevens et al., 2000; Sepulveda et al., 2005). Furthermore, 
the phenotype of Oca-br/- mice highlights a broader role for OCA-B in B 
cell differentiation and function. Even more interesting was the finding 
that OCA-B is one of a relatively small group of proteins that makes use 
of two in-frame translation initiation start sites. Furthermore, one of the 
resulting OCA-B isoforms (p35) is myristoylated and localized to the 
cytoplasm/membrane (Yu et al., 2001). This finding raises yet another 
interesting possibility, that OCA-B could function directly in signaling 
pathways. Indeed, this study has uncovered the highly unique two-fold 
role that OCA-B plays in B cell development and proliferation. OCA-B 
functions in an unprecedented manner - not only by regulating 
expression of its transcriptional targets within the nucleus as a classic 
coactivator but also by functioning directly in signaling pathways by 
regulating kinase protein stability. Collectively, these findings explain 
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w h y O C A - B is critical for m a n y aspects of B cell differentiation and 
function such as pre-BCR and BCR signaling, pre-B cell differentiation, 
germinal center formation, cellular proliferation, secondary isotype 
expression, plasma cell differentiation and maintenance of the re-
circulating B cell pool. 
OCA-B in Early B Cell Development and Signaling 
Although Oca-b/- mice are most obviously defective in antigen-dependent 
B cell development, more subtle yet, important, defects are apparent in 
early B cell development. This study has identified the first block in B 
cell development that occurs as a result of OCA-B deficiency. This defect 
is caused by the failure of pre-BCR signaling, which occurs by a two-fold 
mechanism. First, expression levels of OCA-B target genes such as IgP 
and LCK are reduced in Oca-b/- pre-B cells. Although the specific role of 
LCK in B cells remains to be determined, Ig(3 is the signaling component 
of the pre-BCR and its reduced expression is likely to contribute to the 
early B cell defects of Oca-br/- mice. Furthermore, it is likely that 
unidentified OCA-B target genes play a role in mediating pre-BCR 
responsiveness. The second and more direct mechanism by which OCA-
B mediates pre-BCR signaling is through stabilization of the protein 
tyrosine kinase SYK. As evidenced from this study and previous reports 
(Cheng et al., 1995; Turner et al., 1995; Saijo et al., 2003) SYK is critical 
for early B cell development and pre-BCR signaling. 
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Despite the role of O C A - B in pre-BCR signaling, pre-B2 cells are present 
in Oca-b/- mice at half of the normal amount. However, Oca-b'/' B cells 
once again fail to develop normally at the immature stage such that 
reduced Vk promoter usage causes a reduction in splenic transitional B 
cells (Casellas et al., 2002; Jankovic et al., 2003). This defect is due to 
the classic function of OCA-B as a transcriptional coactivator on a subset 
of octamer-containing Vk promoters. 
The Possible Function of OCA-B in Bl Cell Development 
This study also demonstrates that Oca-br/- mice have an increased 
population of Bla cells in the peritoneum, a phenotype that is also 
observed in Lck-/- mice. Furthermore, we demonstrate that LCK is a 
direct OCA-B target gene that is expressed in Bla cells. However, 
because there are conflicting reports as to the nature of the Bla cell 
defect in Lck-/- mice (Ulivieri et al., 2003; Dal Porto et al., 2004; Frances 
et al., 2005), these findings will need to be developed further in order to 
investigate the functional significance of LCK expression and regulation 
by OCA-B in B cells. Analysis of tyrosine phosphorylation showed that 
Oca-b'/' Bla cells have reduced responsiveness to B cell signaling 
pathways and it is likely that reduced SYK stability contributes to the 
signaling defect of Oca-br/- Bla cells. 
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O C A - B Function in Mature B Cell Differentiation and Activation 
Multiple peripheral B cell subtypes are affected by the absence of OCA-B, 
which can be largely attributed to defective BCR signaling resulting from 
SYK instability and reduced expression of target genes in Oca-b'/' mice. 
This study has identified and validated OCA-B target genes in mature B 
cells through a combination of cDNA array analysis, QPCR, blotting, 
immunohistochemistry, and ChIP assays. While the specific contribution 
of reduced expression of these genes to the phenotype of Oca-b'/- mice 
will need to be determined by mutagenesis studies, they are likely to play 
important roles in B cell function (Chapter 2 and Kim et al., 2003). This 
study, amongst others (Samardzic et al., 2002) has found Oca-br/- mice to 
be deficient in marginal zone B cells. It is possible that this defect could 
be attributed to a reduced B cell migration caused by reduced expression 
of OCA-B target genes such as BAFFR and BCMA (Samardzic et al., 
2002). However, it is also likely that defective BCR signaling caused by 
SYK instability contributes to the reduction of marginal zone B cells in 
Oca-b/- mice. 
As mentioned previously, a multitude of studies have established a 
function for OCA-B in a wide range of processes such as germinal center 
formation, B cell activation, BCR signaling, and plasma cell 
differentiation (Kim et al., 1996; Nielsen et al., 1996; Schubart et al., 
1996b; reviewed in Teitell, 2003). The failure of Oca-b/- mice to 
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efficiently undergo antigen-dependent B cell differentiation can be 
explained by the sequential two-fold function of OCA-B. First, OCA-B 
mediates proximal BCR signaling by directly regulating SYK protein 
stability. The reduction of SYK protein levels provides an explanation for 
the reduction of BCR-induced Calcium-flux in Oca-b'/' cells. This is 
particularly interesting given that this study has demonstrated that 
OCA-B target genes are activated at later stages of B cell activation, post-
OCA-B induction. Conversely, the interaction between OCA-B and SYK 
occurs early in B cell activation when OCA-B protein levels are relatively 
low. Interestingly, we find that OCA-B and SYK protein levels are 
inversely correlated; however, we observe a redistribution of OCA-B 
immediately following BCR stimulation. The alteration of OCA-B 
localization throughout B cell activation may be one way the cell is able 
to control the mode of OCA-B function. 
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Animals 
8-10 week old female Oca-b'/- mice (Kim et al., 1996) and C57BL/6J mice 
(The Jackson Laboratory, Bar Harbor, ME) were used for all experiments. 
Syk conditional knockout mice were also used {Syk-/-) (Saijo et al., 2003). 
All mice were maintained under specific pathogen-free conditions at the 
laboratory animal research center within The Rockefeller University. 
Cell Lines 
MPC11, a mouse plasmacytoma cell line, was maintained in Dulbecco's 
modified Eagle's medium (DMEM) supplemented with 4 mM L-glutamine 
and 10% Horse Serum. Namalwa, a human burkitt's lymphoma cell 
line, was maintained in RPMI 1640 medium supplemented with 2 mM L-
glutamine, 1.0 mM sodium pyruvate, and 10% fetal bovine serum. 
Daudi, a human burkitt's lymphoma cell line, was maintained in RPMI 
1640 medium supplemented with 2 mM L-glutamine, 1.0 mM sodium 
pyruvate, and 10% fetal bovine serum. A20, a mouse lymphoblastic B 
cell line, was maintained in RPMI 1640 medium supplemented with 2 
mM L-glutamine, 1.0 mM sodium pyruvate, 0.05 mM 2-mercaptoethanol, 
and 10% Fetal Bovine Serum. HelaS, a human carcinoma cell line and 
293T, a human fibroblast cell line were maintained in DMEM 
supplemented with 2 mM L-glutamine and 10% Fetal Bovine Serum. 
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Flow Cytometry Analysis and Cell Sorting 
Bone marrow cells were flushed from the femurs and tibia of 5-8 mice 
using PBS supplemented with 10% Fetal Bovine Serum. Splenocytes 
were obtained by crushing spleens in RPMI 1640 supplemented with 
10% Fetal Bovine Serum. Bla cells were obtained by peritoneal lavage 
with PBS. The cell suspensions were prepared for staining according to 
standard procedure (Kim et al, 2000). The samples (1 X 106 cells) were 
analyzed on a FACsort (BD Biosciences, Mountain View, CA) using 
CellQuest software (BD Biosciences, Mountain View, CA) until 2 x 105 
events were acquired. Cell surface markers were detected using the 
following antibodies (all from BD PharMingen, San Diego, CA): B220-PE 
(clone RA3-6B2), B220-FITC, CD43-FITC (clone S7), CD117 (clone 2B8), 
IgM-APC (clone 11/41), CD19-PE (clone 1D3), CD19-APC (clone 6D5), 
CD25-APC (clone PC61), CD25-PE (clone PC61), IgD-PE (clone 11-
26c.2a), pre-BCR (clone SL-156)-streptavidin-PE, k-PE (clone 187.1), 
CD138-PE (clone 281-2), CD21-FITC (clone 7G6), CDllb/MAC-1-PE, 
and CD5-PE. Cell size analysis was performed from five independent 
experiments. The large cells were gated (FSC-H > 375) and the 
percentages obtained were used in a Student's T Test to determine if the 
values obtained from the wildtype samples were statistically distinct from 
that of Oca-b/ . Total bone marrow cells from 10-12 female mice were 
isolated and stained (as described above) for cell sorting using the FACS 
Vantage SE (BD Biosciences, Mountain View, CA). Dead cells and 
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doublets were excluded based on propidium iodide (BD PharMingen, San 
Diego, CA) incorporation and laser scatter patterns, respectively. Post-
sort analysis was performed to access the purity of all the fractions 
collected. For Figure 2.2.7, five to ten mice were immunized 5 days prior 
to sorting with 100 \xg of DNP-keyhole limpet hemocyanin (KLH, 
Calbiochem, La Jolla, CA). 
Quantitiative PCR and RT-PCR 
For the quantitative PCR experiments presented in Chapter 2, DNase-
treated total RNA preparations (2 mg) were reverse transcribed using 
Superscript II reverse transcription kit (Invitrogen, Carlsbad, CA). The 
20 ml reverse transcription reaction was first diluted 10-fold followed by 
3-fold serial dilutions over a 250-fold range to generate standard curves. 
The same RNA stock was used for both quantitative PCR and cDNA 
microarray. Primers (Sigma, USA) were designed for each gene using the 
Primer Express program (Applied Biosytems, Foster City, CA). The 
primer sequences are as follows: Pol2E sense, 
TCAAGGTATACTGCCAGCGCA, and antisense, GTCCACCAGGAACT 
GCTTGG; Kcnn4 sense, ATCGGACTCATGGTTCTGCAC, and antisense, 
GCAGTGGACAGGGTGATCAA; Cdc37 sense, CCACCTGGTGTGTGA 
GGAAA, and antisense, TCTGGTGAGCTACCTGCTCC; and Lck sense, 
CCATGATGGAGACTTGGGCT, and antisense, CTTCTTGGCCAGTCG 
TCAGG. Primer quality (lack of primer-dimer amplification) was 
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confirmed by melting curve analysis using the ABI Prism 7 9 0 0 H T 
Sequence Detection System (Applied Biosystems, Foster City, CA). The 
final 20 ml reaction consisted of 0.425-100 ng template, IX Quantitect 
SYBR Green master mix (Qiagen, Valencia, CA), and 30 ng gene-specific 
primers. All solutions were distributed to 384 well plates using the 
Hydra96 HTS automatic dispensing system (Robbins Scientific, USA). 
The PCR was as follows: 2 min 50° C, 10 min at 95° C, and then 40 cycles 
of 15 sec at 95° C followed by 1 min at 60° C. Relative quantification 
based on standard curves was used for data analysis. The relative 
abundance was calculated using the efficiency-calibrated equation 
described previously (Pfaffi, 2001, Soong et al., 2000). Briefly, the slope 
of each standard curve was used to calculate PCR efficiency (E=101/sl°Pe). 
The final ratio was generated using the following equation: Ratio= 
[(Eref)ctsamPle/(Etarget)ctsample)/ ((Eref)ctcontrol/(Etarget)ctcontro1]. RNA polymerase 
II (RBP5, AW413738) gene was found to be unregulated in all of the array 
experiments and was used as a reference gene. 
For the quantitative PCR experiments presented in Chapters 3 and 4, 
DNase-treated total RNA preparations were reverse transcribed using the 
Superscript II reverse transcription kit (Invitrogen, Carlsbad, CA). 
Subsequent RT-PCR was carried out according to standard protocols 
using cycle numbers within the linear range of amplification for each 
gene, as determined by quantitative PCR (Kim et al., 2003). Quantitative 
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P C R was performed as described above and in Kim et al., 2003 with 
minor modifications. For these experiments the reference gene was 
Gapdh, although similar results were obtained using the RBP5 subunit 
of RNA polymerase II. Additional primer sequences are as follows: Cyclin 
D3 sense, CACAGATGTCACAGCCATTC, and antisense, ATTGTTCTAG 
AGGCAGGGAGGG; Oca-b sense, CGGAGTATGTGTCCCATGAA, and 
antisense, TGATGAGTGGTGGAGAAGCA; Gapdh sense, TCAACT 
ACATGGTCTACATGTTCGAG, and antisense, ACCATTCTCGGCCTTG 
ACTGT; Vpre-b sense, CCCAGGTTCCTGCTGAGATA, and antisense, 
TGCTCAGATACCCCAGGTTC; X5 sense, GTCCCTGTCACTCAGGG TGT, 
and antisense, GAGGCATCCACTGGTCAGAT; Iga sense, TCATA 
CGCCTGTTTGGGTC, and antisense, AGGGTTCCTGCCATTGTTT; Igfi 
sense, CCTCCTCATCATCCTCTTCATC, and antisense, GGTGGCTGT 
CTGGTCAATG; Rag2 sense, ATGGATTTGGAAGAACGCAC, and antisense, 
GGAGGGATTTCATTGGAGGT; Constant sense, TAAATGTGT 
TCGTCCCACCA, and antisense, GAGCTTCCCATCCTTTAGCC; Btk sense, 
AAGTTTCCAGTTCGGTGGTCTC, and antisense, GCAATGTGTT 
CTGCTGTCTCACT; Lyn sense, GTATCAGCAGCAACCGTAGTGG, and 
antisense, CATCAGGAACCAGGAACACAGA; Fyn sense, GACCTCCA 
TCCCGAACTACAAC, and antisense, ATCTTCCGTCCGTGCTTCATAG; 
Syk sense, ATGAGAAGATGCCCTGGTTCC, and antisense, TGTCCCT 
GTCAATGCGGTAGT; Blimp-1 sense, ACACAGTTCCCAAGAATGCCAAC 
AG, and antisense, CGCAAAGTCCCGACAATACCACAC. 
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Northern Blotting 
CDNA clones of various OCA-B target genes were digested with 
restriction enzymes for the generation of radio-labeled probes that were 
hybridized to RNA blots according to standard procedures. The samples 
were normalized using the 18s rRNA signal. The data was quantified 
using a phosphorimager. 
Immunoblotting 
Immunoblotting was carried out with whole cell extract according to 
standard procedure. The antibodies employed were: anti-OCA-B (C-20), 
anti-SYK (N-19) anti-LCK (2102), anti-CDC37 (E-4), anti-ERK2, anti-FYN 
(fyn3) (all from Santa Cruz Biotechnology, Santa Cruz, CA), anti-
phosphoSYK (Tyr323) (Cell Signaling Technology, Beverly, MA), anti-
phosphotyrosine (4G10, Upstate Biotechnology, Charlottesville, VA) anti-
Actin (Sigma, USA), and anti-KCNN4 (a gift of K. Nehrke). 
Transient Transfection 
HelaS or 293T cells were transfected using Lipofectamine (Invitrogen, 
Carlsbad, CA) or Fugene (Roche, USA). Renilla Luciferase activity was 
analyzed 48 hours-post transfection using a luciferase assay kit that 
included PRL-CMV for normalization (Promega, Madison, WI). 
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Primary B Cell Culture 
For the experiments presented in Chapter 2, resting splenic B cells were 
purified as described before (Defranco et al., 1982, Kim et al., 1996) 
using complement-mediated lysis of Thy-1+ cells followed by Percoll 
(Amersham, Piscataway, NJ) gradient centrifugation to isolate high 
density cells. Splenocytes from 20 female mice (5-8 weeks old, in B6 x 
129Sv background) per genotype were pooled in order to obtain sufficient 
numbers of purified resting B cells and to normalize any variations in 
gene expression among the mice. For a given experiment, 60% of the 
cells were designated as resting B cells and used to make RNA or whole 
cell extract without stimulation. The remaining cells were cultured in 
RPMI supplemented with heat inactivated 10% fetal bovine serum in the 
presence of 30 mg/ml anti-mouse IgM Ffab^ fragment (Pierce 
Biotechnology, Rockford, IL) for BCR stimulation. For co-stimulation, 5 
mg/ml anti-mouse IgM F(ab')2, 10 mg/ml anti-CD40 antibody (BD 
Pharmingen, San Diego, CA) and 10 ng/ml recombinant mouse IL-4 
(Sigma, USA) were used. Typical preparations contained at least 90% 
B220+ cells (not shown). Cell suspensions containing Bla cells were 
obtained by peritoneal lavage with PBS. For the experiments presented 
in Chapter 3, CD19+ B cells from bone marrow were isolated by MACS 
(Miltenyi Biotec, Auburn, CA) and cultured without feeder cells using 
RPMI supplemented with 20% FBS, 0.05 mM (3-ME, 100 U/ml P/S, and 
5 ng/ml recombinant IL-7 (Sigma, USA). Fresh IL-7 was added every 72 
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hours. Flow cytometry analysis was performed, as above, to analyze 
cellular proliferation, size, and cell surface marker expression over a 
time-course of IL-7 exposure. For the experiments presented in Chapter 
4, splenocytes from 10 female mice were harvested and splenic B cells 
were enriched by complement-mediated lysis of Thy-1+ cells followed by a 
Percoll gradient (Defranco et al., 1982) to separate dead cells and debris, 
or to fractionate resting B cells (Figure 4G). Preparations were 
determined to contain at least 92% live B220+ cells by flow cytometry (not 
shown). The cells were stimulated as described previously (Kim et al., 
2003). To analyze protein stability, cycloheximide was added in some 
cases at a concentration of 10 Lig/ml. 
cDNA Microarray 
Microarray assays used an indirect labeling method using 5-(3-
aminoallyl)-dUTP and amino-reactive fluorescent dyes Alexa 555 and 
Alexa 647 (Molecular Probes, Carlsbad, CA). Glass cDNA array slides 
containing 9,800 PCR-amplified mouse cDNA clones (Research Genetics, 
Huntsville, AL) were from the Rockefeller University Gene Array Core 
Facility. Hybridization and washing were done in a Hybstation (GeneTAC, 
Ann Arbor, MI) and slides were scanned in a 428 Glass Array Scanner 
(Affymetrix, Santa Clara, CA). For data analyses and clustering, data 
acquired by GENEPIX PRO 3.0 (Amersham Pharmacia, Piscataway, NJ) 
software were directly uploaded into the TANGO (Transcriptome ANalysis 
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of GenOmes) program (Altmann et al., 2001). Quality control 
experiments were carried out to determine optimal RNA concentrations, 
and yellow test experiments in which duplicate RNA samples from a 
single source were labeled with Alexa 555 or Alexa 647 dye were 
performed to determine the inherent noise levels. For expression profiling 
of the WT B cells in response to BCR stimulation, four replicate probe 
labelings and hybridizations were carried out. Three replicate 
experiments were done with Oca-br I- B cells. The TANGO query program 
was used to select genes whose intensity values in each channel were 
above two standard deviations of background and whose stimulated-
resting values were at least 2. The output was further filtered by 
selecting for genes whose expression changed in at least three replicate 
experiments. For costimulation experiments, we carried out dye-flip 
replicates (in which reverse combinations of dyes were used to label the 
resting and stimulated samples) for each time point. Genes whose 
expression changed in both of the two replicates were selected. The 
filtered genes were clustered by using Profile- and K-means clustering (P 
= 0.05) (Tavazoie et al., 1999). Verification of representative genes by 
quantitative real-time PCR and Northern blot indicated that the 
frequency of false positives was 5%. 
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Pre-BCR Crosslinking 
CD19+ cells were cultured in IL-7-containing media (as above) for 48 
hours. Cultures were then depleted of IgK+ cells using biotinylated anti-K 
(BD Pharmingen, San Diego, CA) conjugated to streptavidin dynabeads 
(Dynal Biotech, Brown Deer, WI). Depleted fractions were washed and 
cultured for 4 hours without serum or IL-7 and then stimulated at 37°C 
with 10 Mg/ml anti-IgM Ffab^ (Pierce Biotechnology, Rockford, IL). The 
cells were washed with PBS/1 mM Na3V04 and lysed with 
NP40/Vanadate buffer (1.5% NP40, 1 mM PMSF, 1 mM NaF, 1 mM 
Na3V04, and 20 liM Leupeptin). Following electrophoresis and transfer, 
tyrosine phosphorylation was accessed using anti-phosphotyrosine 
(4G10, Upstate Biotechnology, Charlottesville, VA). Blots were stripped 
and then probed with antibodies (all from Santa Cruz Biotechnology, 
Santa Cruz, CA) to SYK (LR), LCK, FYN (fyn3), ERK, or ACTIN (Sigma, 
USA). 
Protein-Protein Interaction Studies 
For immunoprecipitation, lysates were incubated with anti-OCA-B, anti-
SYK, or rabbit IgG (control) for two hours followed by incubation with 
Protein A-Sepharose (Amersham, Piscataway, NJ). The immuno-
precipitate was then washed four times with lysis buffer. The 
precipitated proteins were resolved by SDS-PAGE and analyzed by 
immunoblot. cDNAs encoding OCA-B residues 1-256, 1-154, and 154-
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256, or S Y K 1-629 were inserted into the G X 4 1 or PET28a plasmids, 
respectively. The proteins were expressed and purified from E. coli 
according to standard procedures. For the GST-protein-protein 
interaction experiments, 10[xg of GST-OCA-B protein was bound to 
glutathione-Sepharose (Amersham, Piscataway, NJ) and incubated with 
approximately 250 ng of purified 6x-Histidine-tagged SYK for three hours 
at 4°C. The beads were washed 6 times with binding buffer [20 mM Tris-
HCl (pH 7.4), 20% Glycerol, 0.2 mM EDTA, 0.1% NP40, 0.2 mM PMSF, 
and 400 mM KC1]. The bound proteins were resolved by SDS-PAGE and 
analyzed by immunoblot. For the Ni-NTA pull-down experiments, 10 ug 
of purified his-tagged SYK was incubated with extracts from Namalwa 
cells for three hours in binding buffer [20 mM Tris-HCl (pH 7.4), 10% 
Glycerol, 30 mM Imidazol, 0.1% NP40, 1.0 mM PMSF, 0.2 mg/ml BSA 
and 150 mM NaCl]. The beads were washed 6 times with binding buffer 
and bound proteins were resolved by SDS-PAGE and analyzed by 
immunoblotting. Cytoplasmic and nuclear extracts were prepared 
according to standard procedure (Dignam et al., 1983). 
Immunofluorescence Microscopy 
Namalwa cells were treated with goat anti-human IgM F(ab')2 (Southern 
Biotechnology. Birmingham, AL) or with anti-human IgM F(ab')2, anti-
human CD40 and recombinant human IL-4 for various lengths of time 
before fixation with 2% paraformadehyde. Cells were permeabilized 
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using 0.5% saponin and incubated with anti-SYK (4D10) (Santa Cruz 
Biotechnology, Santa Cruz, CA) and/or anti-OCA-B. The secondary 
antibodies used were AlexaFluor488-conjugated chicken anti-rabbit IgG, 
AlexaFluor488-conjugated chicken anti-mouse IgG, AlexaFluor546-
conjugated goat anti-rabbit IgG, AlexaFluor546-conjugated donkey anti-
goat IgG (Molecular Probes, Carlsbad, CA). 
Chromatin Immunoprecipitation Assay 
Chromatin immunoprecipitation assays were performed as described 
(Shang et al., 2000) with minor modifications. Antibodies used included 
OCA-B (C-20), OCT-1 (C-21), and OCT-2 (C-20) (Santa Cruz 
Biotechnology, Santa Cruz, CA). The primers used were as follows: Kcnn4 
sense, CACAGGACACAGAGTGGGAAGGAGTTGTAA, and antisense, GAA 
CGTGACTCTGGGAATAGGATGTTGTGT; Lck sense, GGCTCTCTTTGG 
ATCTCTTACCCAGGAGTAT, and anti-sense, GTTCTGGAGGTGAAGAC 
AGGAATGGCTA. 
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